data_2n78_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n78 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.727 ' C ' ' H ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.879 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.727 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.879 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 HG11 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.497 ' H ' HG11 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.3 t-160 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.582 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.474 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 50' ' ' GLY . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.672 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.672 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.433 HG21 ' N ' ' A' ' 68' ' ' THR . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HE ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.652 0.263 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.744 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.832 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.744 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.832 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG23 HH21 ' A' ' 23' ' ' ARG . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.739 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 11.3 t-160 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.739 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.465 ' H ' ' HG3' ' A' ' 46' ' ' ARG . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.406 ' CG2' HG12 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG2' HG12 ' A' ' 67' ' ' ILE . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 64' ' ' LYS . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.7 ' HE ' ' NH2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.7 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 17' ' ' LEU . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.537 ' N ' ' HG1' ' A' ' 16' ' ' THR . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.706 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.851 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.706 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.851 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.672 ' CG1' ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.672 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 43' ' ' ASN . 1.3 m120 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.428 ' CG ' ' CG2' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.763 ' C ' ' H ' ' A' ' 28' ' ' ASN . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.913 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.763 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.913 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 23.6 t60 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.472 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.509 ' HG ' ' NH2' ' A' ' 66' ' ' ARG . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 50' ' ' GLY . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 51' ' ' ASP . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.783 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' NH2' ' HG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.571 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.838 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.613 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 13' ' ' VAL . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.593 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.71 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.883 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.71 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.883 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.522 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 6.3 p-80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.763 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 68' ' ' THR . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.715 0.293 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.521 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.647 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.486 ' HB2' HD22 ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.728 ' C ' ' H ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.728 ' H ' ' C ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.639 ' HD1' ' H ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.639 ' H ' ' HD1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.512 HG11 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.512 ' H ' HG11 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.556 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 4.3 p-80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.449 ' N ' HD13 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 68' ' ' THR . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.618 0.247 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.417 ' H ' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' OG1' ' A' ' 33' ' ' THR . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.882 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 1.6 p-10 -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.882 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.632 ' CG1' ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.632 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 8.3 t-80 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.486 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.458 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.549 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.443 ' H ' HD13 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.434 HG23 ' CG2' ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.549 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.742 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.895 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.742 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.895 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.478 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 45' ' ' ILE . 16.3 m120 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.743 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 68' ' ' THR . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.638 ' OD1' ' NH2' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' C ' ' HG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.65 ' HG1' ' C ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.638 ' NH2' ' OD1' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.882 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.882 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' HG21 ' A' ' 36' ' ' ILE . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.665 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.491 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.728 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.635 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.47 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.519 0.2 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.729 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.915 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.729 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.915 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.606 ' CG1' ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.606 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 11.9 m120 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.755 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.633 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.777 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.564 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.564 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 t-20 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG23 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 64' ' ' LYS . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.668 0.271 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.591 ' OD2' ' NE ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.508 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.418 ' CD1' HG22 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.591 ' NE ' ' OD2' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.926 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.4 t-20 -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.926 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.7 ' CG1' ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.7 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 5.0 m120 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.43 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 ' CG2' HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.589 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.608 0.242 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.736 ' C ' ' H ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.895 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.736 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.895 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.492 HG13 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG13 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.576 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 1.6 m-70 -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 10.3 m120 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.661 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 49' ' ' THR . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.487 ' N ' HD23 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.669 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 68' ' ' THR . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.501 ' H ' ' HG ' ' A' ' 6' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.54 0.21 . . . . 0.0 110.461 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.413 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 19' ' ' ASN . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.881 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.881 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.523 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.2 t-160 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.666 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.488 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 50' ' ' GLY . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' MET . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.538 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 68' ' ' THR . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.666 ' NH2' HH21 ' A' ' 41' ' ' ARG . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.712 0.291 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.711 ' C ' ' H ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.87 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.711 ' H ' ' C ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.87 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.682 ' CG1' ' H ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.682 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 19.6 t-160 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 7.7 t30 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' N ' ' C ' ' A' ' 58' ' ' THR . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.482 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 68' ' ' THR . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.852 0.358 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.89 178.01 7.23 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -163.98 15.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.29 108.56 1.96 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' CG ' ' N ' ' A' ' 6' ' ' SER . 14.7 p-10 -132.87 -145.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 5' ' ' ASP . 2.5 t -91.38 151.12 20.97 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.269 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.727 ' C ' ' H ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.879 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.727 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.879 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 HG11 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.497 ' H ' HG11 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.3 t-160 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.582 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.474 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 50' ' ' GLY . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.672 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.672 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.433 HG21 ' N ' ' A' ' 68' ' ' THR . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.474 ' HE ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.893 0.378 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 m -71.56 -164.57 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 tptp 54.9 68.48 0.86 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.762 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -173.43 130.31 0.45 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.58 128.92 37.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -149.62 -175.18 4.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.744 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.832 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.744 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.832 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG23 HH21 ' A' ' 23' ' ' ARG . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.495 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.739 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 11.3 t-160 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.739 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.465 ' H ' ' HG3' ' A' ' 46' ' ' ARG . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.406 ' CG2' HG12 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG2' HG12 ' A' ' 67' ' ' ILE . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 64' ' ' LYS . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.7 ' HE ' ' NH2' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.7 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.838 0.351 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -58.67 160.11 5.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.672 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.67 -178.15 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 53.31 87.25 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' OD1' ' CE2' ' A' ' 7' ' ' PHE . 3.1 p30 -164.94 151.27 10.31 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m -81.3 -179.28 7.29 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CE2' ' OD1' ' A' ' 5' ' ' ASP . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 17' ' ' LEU . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.537 ' N ' ' HG1' ' A' ' 16' ' ' THR . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.706 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.851 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.706 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.851 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.672 ' CG1' ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.672 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' N ' HD21 ' A' ' 43' ' ' ASN . 1.3 m120 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.428 ' CG ' ' CG2' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.637 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.559 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.978 0.418 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.55 -165.76 0.22 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.964 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -88.97 158.74 17.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -144.24 -118.49 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -153.33 57.15 0.77 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.826 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.22 -177.26 4.06 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.819 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.763 ' C ' ' H ' ' A' ' 28' ' ' ASN . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.913 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.763 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.913 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 23.6 t60 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.472 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.509 ' HG ' ' NH2' ' A' ' 66' ' ' ARG . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 50' ' ' GLY . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 51' ' ' ASP . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.783 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' NH2' ' HG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' HB3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.571 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.9 0.381 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m 52.17 87.61 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.09 -96.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -120.27 -89.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.582 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.52 20.41 6.31 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.711 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t -65.54 -175.06 0.23 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.613 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 13' ' ' VAL . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.593 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.71 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.883 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.71 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.883 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.45 ' H ' HG13 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.522 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 6.3 p-80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.763 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 HG21 ' N ' ' A' ' 68' ' ' THR . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -55.39 -13.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -75.8 134.72 40.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.74 101.6 2.93 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.799 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -160.69 -44.41 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -166.58 179.95 5.2 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.521 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.647 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.486 ' HB2' HD22 ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.728 ' C ' ' H ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.728 ' H ' ' C ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.639 ' HD1' ' H ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.639 ' H ' ' HD1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.512 HG11 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.512 ' H ' HG11 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.556 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 4.3 p-80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.449 ' N ' HD13 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.471 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.632 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 68' ' ' THR . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.899 0.381 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -153.74 -10.28 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.765 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -151.72 -154.58 0.55 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.848 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.59 -94.4 0.13 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 t70 53.88 27.37 7.14 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.689 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -97.83 175.65 6.08 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.814 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.417 ' H ' HG22 ' A' ' 16' ' ' THR . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' OG1' ' A' ' 33' ' ' THR . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.882 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 1.6 p-10 -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.882 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.632 ' CG1' ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.632 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 8.3 t-80 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.486 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.458 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.549 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.443 ' H ' HD13 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.434 HG23 ' CG2' ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.549 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ptm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.961 0.41 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 3' ' ' LYS . 59.8 p 42.3 -138.82 0.19 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 2' ' ' SER . 15.8 tptt -127.45 168.71 14.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 5' ' ' ASP . 18.0 pt-20 -85.99 -143.47 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.26 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.461 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 t70 -78.06 6.78 7.21 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.448 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 5.7 t -77.54 176.58 8.79 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.742 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.895 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.742 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.895 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.478 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 45' ' ' ILE . 16.3 m120 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.743 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 68' ' ' THR . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.905 0.383 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.2 6.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.962 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -92.72 110.09 21.52 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.953 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 5' ' ' ASP . 9.4 tp10 -148.54 163.74 36.3 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.564 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -93.16 -44.95 8.1 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.028 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -70.25 -177.79 1.51 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.621 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 50' ' ' GLY . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.638 ' OD1' ' NH2' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' C ' ' HG1' ' A' ' 20' ' ' THR . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.65 ' HG1' ' C ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.638 ' NH2' ' OD1' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.882 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.882 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' HG21 ' A' ' 36' ' ' ILE . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.665 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.665 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.491 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.728 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.635 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.47 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' SD ' ' A' ' 1' ' ' MET . 9.6 mmm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.888 0.375 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -77.82 -34.12 52.11 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -94.0 149.67 21.03 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.178 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.47 122.4 2.76 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.6 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 6' ' ' SER . 36.9 t70 -157.95 -117.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -143.88 162.93 34.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.497 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.729 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.915 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.729 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.915 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.606 ' CG1' ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.606 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 11.9 m120 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.755 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.599 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.899 0.381 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -151.67 -99.78 0.06 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.742 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -80.95 100.55 8.98 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 6' ' ' SER . 4.6 tm-20 -144.39 -40.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.878 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.72 23.76 0.23 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 4' ' ' GLU . 58.4 m -156.94 162.75 39.62 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.633 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.777 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.564 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.564 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 t-20 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' N ' HG23 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 64' ' ' LYS . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.616 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -151.23 40.26 0.69 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.831 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.07 -45.06 95.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.32 170.84 18.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 2.6 m-20 -101.58 -170.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.173 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.33 178.36 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.706 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.591 ' OD2' ' NE ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.508 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 ' CD1' HG22 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.591 ' NE ' ' OD2' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.926 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.4 t-20 -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.926 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.7 ' CG1' ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.7 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 5.0 m120 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.43 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 ' CG2' HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.589 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -149.98 111.1 4.38 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -0.89 50.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.72 170.09 17.21 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.804 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 6' ' ' SER . 1.1 p30 -111.91 -115.75 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 63.3 p -58.37 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.836 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.736 ' C ' ' H ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.895 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.736 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.895 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG13 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG13 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.576 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 1.6 m-70 -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 10.3 m120 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.661 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 49' ' ' THR . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.487 ' N ' HD23 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.669 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.669 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 68' ' ' THR . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.907 0.384 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -171.61 122.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -155.91 64.82 0.58 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 22.5 mp0 -86.44 -95.21 0.08 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 61' ' ' ASP . 8.1 t0 -156.14 -64.59 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.864 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.501 ' H ' ' HG ' ' A' ' 6' ' ' SER . 0.8 OUTLIER -46.17 121.75 3.51 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.461 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.454 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.413 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 19' ' ' ASN . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.881 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.881 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.523 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.2 t-160 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.666 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.488 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 50' ' ' GLY . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' MET . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.538 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 68' ' ' THR . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.666 ' NH2' HH21 ' A' ' 41' ' ' ARG . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p 59.19 170.45 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 53.59 82.08 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 88.6 mt-10 -153.56 -40.52 0.1 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.821 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER 68.82 154.79 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.747 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t -64.57 174.47 1.74 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.711 ' C ' ' H ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.87 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.711 ' H ' ' C ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.87 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.682 ' CG1' ' H ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.682 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 19.6 t-160 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 7.7 t30 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' N ' ' C ' ' A' ' 58' ' ' THR . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.482 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 68' ' ' THR . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 57' ' ' LEU . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.694 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 35' ' ' HIS . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 55' ' ' VAL . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.727 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 5.5 t60 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.598 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 70' ' ' ARG . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.635 HD12 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 53' ' ' VAL . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.652 0.263 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' VAL . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.561 HG13 ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 55' ' ' VAL . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.714 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.886 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.714 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.886 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.41 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 6.9 t60 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.465 HG12 ' N ' ' A' ' 37' ' ' SER . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 51' ' ' ASP . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.065 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG12 ' HB3' ' A' ' 70' ' ' ARG . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 24' ' ' VAL . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.772 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.732 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 24' ' ' VAL . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' CG1' HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 17' ' ' LEU . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 55' ' ' VAL . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.912 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.912 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.86 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.486 HG22 ' CG1' ' A' ' 14' ' ' VAL . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 70' ' ' ARG . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.862 HG21 HG11 ' A' ' 24' ' ' VAL . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.832 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 24' ' ' VAL . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.653 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.653 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 24' ' ' VAL . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.79 HD12 HG23 ' A' ' 32' ' ' VAL . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.733 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.5 t-80 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.79 HG23 HD12 ' A' ' 26' ' ' LEU . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.569 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 3.9 t-20 -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 45' ' ' ILE . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.697 HG22 HG13 ' A' ' 14' ' ' VAL . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 70' ' ' ARG . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.076 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 53' ' ' VAL . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.817 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.655 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.838 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.721 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 15.4 t30 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.671 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 55' ' ' VAL . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 26' ' ' LEU . 55.5 t-20 -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 36' ' ' ILE . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 48' ' ' LEU . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.709 HG21 HG12 ' A' ' 67' ' ' ILE . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.876 HG21 HG11 ' A' ' 24' ' ' VAL . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 7' ' ' PHE . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.031 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.709 HG12 HG21 ' A' ' 53' ' ' VAL . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CB ' HG12 ' A' ' 53' ' ' VAL . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.715 0.293 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 57' ' ' LEU . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.444 ' SD ' HD22 ' A' ' 26' ' ' LEU . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.541 ' C ' HG23 ' A' ' 24' ' ' VAL . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.623 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 35.0 p-10 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.623 ' SD ' ' ND2' ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 55' ' ' VAL . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.696 ' O ' ' N ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.742 ' H ' HG12 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 45' ' ' ILE . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 67' ' ' ILE . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 24' ' ' VAL . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 53' ' ' VAL . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.618 0.247 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 24' ' ' VAL . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.852 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.852 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.768 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 15.5 t60 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.579 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.457 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.568 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.672 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 9.0 t-20 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.672 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 24' ' ' VAL . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' N ' ' A' ' 45' ' ' ILE . 92.9 m-20 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.497 ' N ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 14' ' ' VAL . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 70' ' ' ARG . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.059 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.705 ' HA ' HG12 ' A' ' 53' ' ' VAL . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' ' H ' ' A' ' 51' ' ' ASP . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG13 ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.673 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.474 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 55' ' ' VAL . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.707 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.707 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.665 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 32' ' ' VAL . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 39' ' ' LYS . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.634 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.463 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 48' ' ' LEU . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.436 ' OG1' HG13 ' A' ' 14' ' ' VAL . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.545 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 HG12 ' A' ' 67' ' ' ILE . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 24' ' ' VAL . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.054 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.604 HG12 HG21 ' A' ' 53' ' ' VAL . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.519 0.2 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.699 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 26' ' ' LEU . 24.8 p30 -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.754 HG12 ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.754 ' N ' HG12 ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.578 HD11 ' HG2' ' A' ' 40' ' ' MET . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 16.4 m-80 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 70' ' ' ARG . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.012 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 53' ' ' VAL . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.806 ' HB3' HG12 ' A' ' 53' ' ' VAL . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 49' ' ' THR . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 7.2 p30 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.578 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 55' ' ' VAL . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.793 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 41' ' ' ARG . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 51.2 t30 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 14' ' ' VAL . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 70' ' ' ARG . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 24' ' ' VAL . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.827 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.668 0.271 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.749 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' THR . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.69 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 55' ' ' VAL . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.909 HG12 ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.909 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 40' ' ' MET . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 71.9 m-20 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 46' ' ' ARG . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' N ' HG23 ' A' ' 45' ' ' ILE . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.53 HG13 HD23 ' A' ' 48' ' ' LEU . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 7' ' ' PHE . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.745 HG12 HG21 ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.675 ' HB3' HG12 ' A' ' 53' ' ' VAL . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.608 0.242 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 6.5 t30 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HE ' ' CB ' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.867 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.867 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.604 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 8.0 m-80 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.622 ' C ' HD12 ' A' ' 47' ' ' ILE . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.939 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.536 ' N ' HD22 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 67' ' ' ILE . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.54 0.21 . . . . 0.0 110.461 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 17' ' ' LEU . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 12' ' ' THR . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.712 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.846 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.712 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.846 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.68 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 2.7 t60 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.42 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.672 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 14' ' ' VAL . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 70' ' ' ARG . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.542 ' H ' HD12 ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 53' ' ' VAL . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' THR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.742 ' HA ' HG12 ' A' ' 53' ' ' VAL . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.712 0.291 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.491 ' C ' HG23 ' A' ' 24' ' ' VAL . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.432 HG22 ' C ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 17' ' ' LEU . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HE ' ' HB2' ' A' ' 23' ' ' ARG . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 12' ' ' THR . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.773 HG12 ' N ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.773 ' N ' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 18.3 t-20 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 45' ' ' ILE . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 47' ' ' ILE . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' HB ' HG23 ' A' ' 67' ' ' ILE . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 24' ' ' VAL . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' HD21 ' A' ' 62' ' ' LEU . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 53' ' ' VAL . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.852 0.358 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.89 178.01 7.23 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -163.98 15.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.29 108.56 1.96 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' CG ' ' N ' ' A' ' 6' ' ' SER . 14.7 p-10 -132.87 -145.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 5' ' ' ASP . 2.5 t -91.38 151.12 20.97 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.269 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 57' ' ' LEU . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.694 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 35' ' ' HIS . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 55' ' ' VAL . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.727 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 5.5 t60 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.598 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 70' ' ' ARG . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.635 HD12 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 53' ' ' VAL . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.893 0.378 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 m -71.56 -164.57 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 tptp 54.9 68.48 0.86 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.762 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -173.43 130.31 0.45 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.58 128.92 37.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -149.62 -175.18 4.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' VAL . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.561 HG13 ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 55' ' ' VAL . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.714 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.886 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.714 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.886 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.41 ' CG ' ' N ' ' A' ' 36' ' ' ILE . 6.9 t60 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.465 HG12 ' N ' ' A' ' 37' ' ' SER . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 51' ' ' ASP . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.065 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG12 ' HB3' ' A' ' 70' ' ' ARG . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 24' ' ' VAL . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.772 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.732 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.838 0.351 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -58.67 160.11 5.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.672 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.67 -178.15 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 53.31 87.25 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' OD1' ' CE2' ' A' ' 7' ' ' PHE . 3.1 p30 -164.94 151.27 10.31 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m -81.3 -179.28 7.29 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CE2' ' OD1' ' A' ' 5' ' ' ASP . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 24' ' ' VAL . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' CG1' HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 17' ' ' LEU . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 55' ' ' VAL . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.912 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.912 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.86 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.486 HG22 ' CG1' ' A' ' 14' ' ' VAL . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 70' ' ' ARG . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.862 HG21 HG11 ' A' ' 24' ' ' VAL . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.832 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.978 0.418 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.55 -165.76 0.22 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.964 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -88.97 158.74 17.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -144.24 -118.49 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -153.33 57.15 0.77 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.826 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.22 -177.26 4.06 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.819 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 24' ' ' VAL . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.653 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.653 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 24' ' ' VAL . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.79 HD12 HG23 ' A' ' 32' ' ' VAL . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.733 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.5 t-80 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.79 HG23 HD12 ' A' ' 26' ' ' LEU . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.569 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 3.9 t-20 -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 45' ' ' ILE . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.697 HG22 HG13 ' A' ' 14' ' ' VAL . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 70' ' ' ARG . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.076 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 53' ' ' VAL . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.817 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.655 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.9 0.381 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m 52.17 87.61 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.09 -96.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -120.27 -89.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.582 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.52 20.41 6.31 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.711 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t -65.54 -175.06 0.23 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.721 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 15.4 t30 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.671 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 55' ' ' VAL . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 26' ' ' LEU . 55.5 t-20 -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 36' ' ' ILE . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 48' ' ' LEU . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.709 HG21 HG12 ' A' ' 67' ' ' ILE . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.876 HG21 HG11 ' A' ' 24' ' ' VAL . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 7' ' ' PHE . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.031 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.709 HG12 HG21 ' A' ' 53' ' ' VAL . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CB ' HG12 ' A' ' 53' ' ' VAL . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -55.39 -13.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -75.8 134.72 40.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.74 101.6 2.93 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.799 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -160.69 -44.41 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -166.58 179.95 5.2 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 57' ' ' LEU . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.444 ' SD ' HD22 ' A' ' 26' ' ' LEU . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.541 ' C ' HG23 ' A' ' 24' ' ' VAL . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.623 ' ND2' ' SD ' ' A' ' 21' ' ' MET . 35.0 p-10 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.623 ' SD ' ' ND2' ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 55' ' ' VAL . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.696 ' O ' ' N ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.742 ' H ' HG12 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 45' ' ' ILE . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 67' ' ' ILE . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 24' ' ' VAL . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 53' ' ' VAL . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.899 0.381 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -153.74 -10.28 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.765 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -151.72 -154.58 0.55 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.848 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.59 -94.4 0.13 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 t70 53.88 27.37 7.14 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.689 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -97.83 175.65 6.08 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.814 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 24' ' ' VAL . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.852 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.852 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.768 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 15.5 t60 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.579 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.457 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.568 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' C ' ' HG ' ' A' ' 2' ' ' SER . 5.2 ptm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.961 0.41 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HG ' ' C ' ' A' ' 1' ' ' MET . 59.8 p 42.3 -138.82 0.19 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 2' ' ' SER . 15.8 tptt -127.45 168.71 14.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 6' ' ' SER . 18.0 pt-20 -85.99 -143.47 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.26 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 t70 -78.06 6.78 7.21 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.486 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 5.7 t -77.54 176.58 8.79 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.672 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 9.0 t-20 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.672 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 24' ' ' VAL . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' N ' ' A' ' 45' ' ' ILE . 92.9 m-20 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.497 ' N ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 14' ' ' VAL . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 70' ' ' ARG . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.059 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 35' ' ' HIS . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.705 ' HA ' HG12 ' A' ' 53' ' ' VAL . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.905 0.383 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.2 6.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.962 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -92.72 110.09 21.52 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.953 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 5' ' ' ASP . 9.4 tp10 -148.54 163.74 36.3 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.564 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -93.16 -44.95 8.1 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.028 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -70.25 -177.79 1.51 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.621 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' ' H ' ' A' ' 51' ' ' ASP . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG13 ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.673 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.474 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 55' ' ' VAL . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.707 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.707 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.665 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 32' ' ' VAL . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 39' ' ' LYS . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.634 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.463 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 48' ' ' LEU . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.436 ' OG1' HG13 ' A' ' 14' ' ' VAL . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 HG12 ' A' ' 67' ' ' ILE . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 24' ' ' VAL . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.054 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.604 HG12 HG21 ' A' ' 53' ' ' VAL . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 1' ' ' MET . 9.6 mmm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.888 0.375 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -77.82 -34.12 52.11 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -94.0 149.67 21.03 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.178 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.47 122.4 2.76 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.6 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 6' ' ' SER . 36.9 t70 -157.95 -117.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -143.88 162.93 34.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.497 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.699 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 26' ' ' LEU . 24.8 p30 -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.754 HG12 ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.754 ' N ' HG12 ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.578 HD11 ' HG2' ' A' ' 40' ' ' MET . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 16.4 m-80 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 70' ' ' ARG . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.012 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 53' ' ' VAL . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.806 ' HB3' HG12 ' A' ' 53' ' ' VAL . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.899 0.381 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -151.67 -99.78 0.06 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.742 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -80.95 100.55 8.98 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 6' ' ' SER . 4.6 tm-20 -144.39 -40.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.878 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.72 23.76 0.23 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 4' ' ' GLU . 58.4 m -156.94 162.75 39.62 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 49' ' ' THR . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 7.2 p30 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.578 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 55' ' ' VAL . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.793 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 41' ' ' ARG . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 51.2 t30 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 14' ' ' VAL . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 70' ' ' ARG . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 24' ' ' VAL . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.827 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -151.23 40.26 0.69 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.831 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.07 -45.06 95.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.32 170.84 18.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 2.6 m-20 -101.58 -170.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.173 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.33 178.36 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.706 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.749 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' THR . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.69 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 55' ' ' VAL . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.909 HG12 ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.909 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 40' ' ' MET . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 71.9 m-20 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 46' ' ' ARG . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' N ' HG23 ' A' ' 45' ' ' ILE . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.53 HG13 HD23 ' A' ' 48' ' ' LEU . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 7' ' ' PHE . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.745 HG12 HG21 ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' HB3' HG12 ' A' ' 53' ' ' VAL . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -149.98 111.1 4.38 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -0.89 50.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.72 170.09 17.21 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.804 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 6' ' ' SER . 1.1 p30 -111.91 -115.75 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 63.3 p -58.37 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.836 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 6.5 t30 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HE ' ' CB ' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.867 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.867 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.604 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 8.0 m-80 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.622 ' C ' HD12 ' A' ' 47' ' ' ILE . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.939 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.536 ' N ' HD22 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 67' ' ' ILE . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.907 0.384 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -171.61 122.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -155.91 64.82 0.58 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 22.5 mp0 -86.44 -95.21 0.08 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 61' ' ' ASP . 8.1 t0 -156.14 -64.59 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.864 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -46.17 121.75 3.51 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.461 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 17' ' ' LEU . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 12' ' ' THR . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.712 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.846 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.712 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.846 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.68 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 2.7 t60 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 ' O ' ' CE1' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.672 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 14' ' ' VAL . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 70' ' ' ARG . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.542 ' H ' HD12 ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 53' ' ' VAL . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' THR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.742 ' HA ' HG12 ' A' ' 53' ' ' VAL . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p 59.19 170.45 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 53.59 82.08 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 88.6 mt-10 -153.56 -40.52 0.1 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.821 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER 68.82 154.79 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.747 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t -64.57 174.47 1.74 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.491 ' C ' HG23 ' A' ' 24' ' ' VAL . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG22 ' C ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 17' ' ' LEU . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HE ' ' HB2' ' A' ' 23' ' ' ARG . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 12' ' ' THR . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.773 HG12 ' N ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.773 ' N ' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 18.3 t-20 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 45' ' ' ILE . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 47' ' ' ILE . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' HB ' HG23 ' A' ' 67' ' ' ILE . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 24' ' ' VAL . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' HD21 ' A' ' 62' ' ' LEU . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 53' ' ' VAL . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 57' ' ' LEU . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.694 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 55' ' ' VAL . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.727 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.3 t-160 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.582 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.45 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 70' ' ' ARG . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.635 HD12 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 53' ' ' VAL . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.652 0.263 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' VAL . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.561 HG13 ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 55' ' ' VAL . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.714 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.886 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.714 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.886 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.724 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 11.3 t-160 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.724 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 51' ' ' ASP . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.065 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG12 ' HB3' ' A' ' 70' ' ' ARG . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 24' ' ' VAL . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.772 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.732 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 24' ' ' VAL . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' CG1' HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 17' ' ' LEU . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 55' ' ' VAL . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.912 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.912 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.86 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.598 HD22 ' N ' ' A' ' 43' ' ' ASN . 1.3 m120 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.486 HG22 ' CG1' ' A' ' 14' ' ' VAL . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 70' ' ' ARG . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.862 HG21 HG11 ' A' ' 24' ' ' VAL . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.832 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 24' ' ' VAL . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.653 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.653 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 24' ' ' VAL . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.79 HD12 HG23 ' A' ' 32' ' ' VAL . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.733 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 23.6 t60 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.79 HG23 HD12 ' A' ' 26' ' ' LEU . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.569 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' ND2' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' ND2' ' A' ' 43' ' ' ASN . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.697 HG22 HG13 ' A' ' 14' ' ' VAL . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 70' ' ' ARG . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.076 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 53' ' ' VAL . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.817 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.655 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.838 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.721 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.671 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 55' ' ' VAL . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.522 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 6.3 p-80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 36' ' ' ILE . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 48' ' ' LEU . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.709 HG21 HG12 ' A' ' 67' ' ' ILE . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.876 HG21 HG11 ' A' ' 24' ' ' VAL . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 7' ' ' PHE . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.031 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.709 HG12 HG21 ' A' ' 53' ' ' VAL . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CB ' HG12 ' A' ' 53' ' ' VAL . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.715 0.293 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 57' ' ' LEU . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.444 ' SD ' HD22 ' A' ' 26' ' ' LEU . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.541 ' C ' HG23 ' A' ' 24' ' ' VAL . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.521 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.519 ' HB2' HD21 ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 55' ' ' VAL . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.696 ' O ' ' N ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.742 ' H ' HG12 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.556 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 4.3 p-80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 45' ' ' ILE . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 67' ' ' ILE . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 24' ' ' VAL . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 53' ' ' VAL . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.618 0.247 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 24' ' ' VAL . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.852 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 1.6 p-10 -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.852 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.768 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 8.3 t-80 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.457 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.568 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.672 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.672 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 24' ' ' VAL . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' N ' ' A' ' 45' ' ' ILE . 16.3 m120 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.497 ' N ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 14' ' ' VAL . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 70' ' ' ARG . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.059 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.705 ' HA ' HG12 ' A' ' 53' ' ' VAL . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' ' H ' ' A' ' 51' ' ' ASP . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG13 ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.673 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.474 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 55' ' ' VAL . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.707 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.707 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.665 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 32' ' ' VAL . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 39' ' ' LYS . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.634 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.463 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 48' ' ' LEU . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.436 ' OG1' HG13 ' A' ' 14' ' ' VAL . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.545 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 HG12 ' A' ' 67' ' ' ILE . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 24' ' ' VAL . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.054 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.604 HG12 HG21 ' A' ' 53' ' ' VAL . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.519 0.2 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.699 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.754 HG12 ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.754 ' N ' HG12 ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.578 HD11 ' HG2' ' A' ' 40' ' ' MET . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 11.9 m120 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 70' ' ' ARG . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.012 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 53' ' ' VAL . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.806 ' HB3' HG12 ' A' ' 53' ' ' VAL . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 49' ' ' THR . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.633 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.797 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.578 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 55' ' ' VAL . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.793 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 41' ' ' ARG . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 t-20 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 14' ' ' VAL . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 70' ' ' ARG . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 24' ' ' VAL . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.693 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.827 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.668 0.271 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.749 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' THR . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.69 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 55' ' ' VAL . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.4 t-20 -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.909 HG12 ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.909 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 40' ' ' MET . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 5.0 m120 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 46' ' ' ARG . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' N ' HG23 ' A' ' 45' ' ' ILE . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.53 HG13 HD23 ' A' ' 48' ' ' LEU . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 7' ' ' PHE . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.745 HG12 HG21 ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.675 ' HB3' HG12 ' A' ' 53' ' ' VAL . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.608 0.242 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HE ' ' CB ' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.867 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.867 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.604 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.576 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 1.6 m-70 -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 10.3 m120 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.622 ' C ' HD12 ' A' ' 47' ' ' ILE . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.939 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.536 ' N ' HD22 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 67' ' ' ILE . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 120.54 0.21 . . . . 0.0 110.461 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 17' ' ' LEU . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 12' ' ' THR . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.712 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.846 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.712 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.846 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.68 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.2 t-160 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.672 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 14' ' ' VAL . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 70' ' ' ARG . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.542 ' H ' HD12 ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 53' ' ' VAL . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' THR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.742 ' HA ' HG12 ' A' ' 53' ' ' VAL . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.712 0.291 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.491 ' C ' HG23 ' A' ' 24' ' ' VAL . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.432 HG22 ' C ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 17' ' ' LEU . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HE ' ' HB2' ' A' ' 23' ' ' ARG . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 12' ' ' THR . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.773 HG12 ' N ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.773 ' N ' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 7.7 t30 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 45' ' ' ILE . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 47' ' ' ILE . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' HB ' HG23 ' A' ' 67' ' ' ILE . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 24' ' ' VAL . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' HD21 ' A' ' 62' ' ' LEU . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 53' ' ' VAL . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttp . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.852 0.358 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.89 178.01 7.23 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.831 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -163.98 15.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.29 108.56 1.96 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' CG ' ' N ' ' A' ' 6' ' ' SER . 14.7 p-10 -132.87 -145.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 5' ' ' ASP . 2.5 t -91.38 151.12 20.97 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.269 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.635 ' CE2' HD12 ' A' ' 57' ' ' LEU . 4.0 p90 -158.24 164.67 36.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.77 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.558 ' CB ' ' NH1' ' A' ' 54' ' ' ARG . 11.6 mp0 -89.61 155.23 19.38 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.42 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.488 ' N ' ' O ' ' A' ' 55' ' ' VAL . 11.8 ttt -160.48 130.19 5.12 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.023 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.82 143.85 43.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.353 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.53 -170.8 23.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -127.19 152.06 47.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.793 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 50' ' ' GLY . 31.8 t -106.87 103.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.662 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.85 83.22 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.869 0 C-N-CA 117.44 -1.704 . . . . 0.0 110.474 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.694 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 32.7 t70 171.06 149.36 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.446 -2.161 . . . . 0.0 108.663 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 16' ' ' THR . 0.4 OUTLIER -122.0 97.38 5.45 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.161 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -84.7 171.44 11.03 Favored Pre-proline 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.699 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 20.6 Cg_endo -97.22 161.64 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.499 0.799 . . . . 0.0 111.356 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.7 t30 78.87 25.27 0.51 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.356 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 72.62 60.95 0.12 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.05 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 51.7 mtt -147.36 167.71 23.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 21' ' ' MET . 20.5 m-85 -148.24 161.24 41.89 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -97.27 128.06 43.79 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 117.895 -1.522 . . . . 0.0 108.808 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 55' ' ' VAL . 5.5 t -104.79 126.08 59.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.97 130.99 39.87 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.677 1.227 . . . . 0.0 113.291 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' ASN . 95.5 mt -126.87 35.47 4.6 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.4 tp10 -36.91 -6.2 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.273 0 CA-C-N 113.131 -1.85 . . . . 0.0 112.757 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' LEU . 5.9 m120 -71.02 25.77 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.93 -11.02 17.99 Favored Glycine 0 CA--C 1.559 2.839 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.633 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -124.68 152.02 44.23 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 1.4 p -130.42 139.18 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.727 HG12 ' H ' ' A' ' 33' ' ' THR . 2.0 t -148.01 174.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.019 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.727 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.7 m -126.27 109.91 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.763 -1.562 . . . . 0.0 107.95 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.09 -179.77 3.78 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.683 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.3 t-160 -153.43 150.12 28.47 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.555 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.582 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 19.0 tt -104.45 146.88 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.703 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -51.39 157.82 0.95 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.705 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.13 -41.55 11.92 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.276 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -50.0 -52.19 35.83 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.8 OUTLIER -59.34 -46.28 89.05 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.005 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.6 ttp85 -52.84 -47.67 67.56 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.176 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -79.5 -16.44 56.03 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.226 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 47.5 t30 -96.96 0.48 48.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.175 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.506 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 57.8 m-85 -159.63 157.33 29.48 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.059 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mm -72.93 140.6 17.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -76.72 117.05 17.95 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.107 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 ' HE ' ' A' ' 70' ' ' ARG . 6.9 mm -64.27 149.14 11.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.784 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mt -56.31 174.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.211 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.6 t -59.67 151.27 25.33 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.673 1.225 . . . . 0.0 112.831 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 78.83 79.38 0.79 Allowed Glycine 0 C--N 1.274 -2.891 0 CA-C-N 112.391 -2.186 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.45 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -108.72 118.14 36.02 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -76.2 113.98 14.35 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 115.762 -2.375 . . . . 0.0 105.717 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 70' ' ' ARG . 21.5 m -135.55 -176.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 118.313 -1.355 . . . . 0.0 114.323 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.558 ' NH1' ' CB ' ' A' ' 8' ' ' GLU . 5.8 ttt-85 -100.87 120.62 40.41 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.596 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.6 t -101.64 141.73 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.91 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -118.03 114.79 23.67 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.635 HD12 ' CE2' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -94.57 151.81 19.03 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.746 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.2 p -118.12 151.75 49.54 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.098 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -66.58 -29.56 43.9 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 121.886 1.724 . . . . 0.0 112.234 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 61' ' ' ASP . 2.0 p90 -72.84 -4.17 30.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.55 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER 165.42 87.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.256 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' LYS . 39.3 mt -63.17 -28.47 70.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t -57.19 -2.45 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.395 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' LEU . 17.9 mttp -134.18 143.98 48.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.484 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.94 -171.81 29.65 Favored Glycine 0 C--N 1.291 -1.956 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -134.12 166.33 23.0 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.521 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 HG21 ' A' ' 53' ' ' VAL . 50.0 mt -104.37 142.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.296 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -160.27 86.1 0.74 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.777 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.9 t80 119.14 124.07 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 CA-C-N 111.774 -2.466 . . . . 0.0 108.397 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.71 153.39 43.98 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.136 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.82 42.62 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.402 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 116.265 -1.826 . . . . 0.0 110.811 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.893 0.378 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 m -71.56 -164.57 0.12 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 tptp 54.9 68.48 0.86 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.762 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -173.43 130.31 0.45 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.58 128.92 37.98 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.592 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -149.62 -175.18 4.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.106 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 19.5 m-85 -126.34 127.12 45.02 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' OE1' ' CZ ' ' A' ' 54' ' ' ARG . 8.4 pt-20 -91.27 139.38 30.79 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttt -160.61 124.95 3.62 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.636 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -77.89 144.08 37.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.467 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.16 162.45 30.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' VAL . 53.4 m -96.86 153.1 18.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.232 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLY . 75.9 t -104.7 111.22 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.733 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.561 HG13 ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -149.72 82.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 C-N-CA 118.138 -1.425 . . . . 0.0 110.485 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.575 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 4.6 m-20 169.23 142.86 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 113.133 -1.848 . . . . 0.0 107.956 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.05 143.91 39.39 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.699 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 17' ' ' LEU . 38.8 mt -128.33 169.55 12.5 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.1 Cg_endo -96.98 161.84 1.04 Allowed 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.659 0.906 . . . . 0.0 111.411 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 10.7 t30 77.34 32.98 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.791 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 m 62.66 59.55 1.44 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.223 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.652 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mtt -136.71 173.25 11.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.911 -1.115 . . . . 0.0 112.026 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD1' ' C ' ' A' ' 21' ' ' MET . 7.7 m-85 -154.79 172.0 18.67 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.311 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.575 ' NH1' ' OD2' ' A' ' 15' ' ' ASP . 4.8 ttt180 -125.65 142.01 51.73 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.077 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 55' ' ' VAL . 13.8 p -115.73 139.61 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.985 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -96.16 125.99 41.07 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.584 1.183 . . . . 0.0 113.906 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.714 ' C ' ' H ' ' A' ' 28' ' ' ASN . 79.4 mt -113.25 36.47 3.53 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.886 ' C ' ' H ' ' A' ' 29' ' ' GLY . 5.4 tt0 -36.17 -5.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.273 -2.24 . . . . 0.0 112.788 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.714 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.3 m120 -71.18 25.7 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.886 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.2 -14.65 15.96 Favored Glycine 0 CA--C 1.562 2.997 0 CA-C-N 113.497 -1.683 . . . . 0.0 111.277 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' O ' ' C ' ' A' ' 26' ' ' LEU . 88.9 m-70 -125.2 155.85 39.38 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 34.5 t -131.23 149.07 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -150.32 173.05 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 117.436 -1.706 . . . . 0.0 113.183 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -120.19 134.91 55.15 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.283 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.23 179.38 8.35 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.244 -1.383 . . . . 0.0 111.888 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.724 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 11.3 t-160 -132.76 157.99 43.53 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.791 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.724 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 8.0 tt -98.25 158.29 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.271 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 36' ' ' ILE . 3.2 m -84.41 163.41 19.52 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.38 -31.24 38.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.596 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -48.86 -53.65 18.54 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 mmm -50.34 -41.19 51.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -38.32 90.6 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' TYR . 10.4 mtmt -63.4 -25.06 68.11 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.406 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.5 -2.11 3.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.254 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' LYS . 3.0 t80 67.5 53.29 0.74 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.307 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 45' ' ' ILE . 29.1 mt -149.88 121.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -75.27 163.81 27.1 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.706 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.773 HD11 ' OD2' ' A' ' 51' ' ' ASP . 7.5 tt -106.28 134.56 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.584 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.065 HD23 ' H ' ' A' ' 48' ' ' LEU . 2.1 pt? -102.99 155.12 18.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' VAL . 1.8 m -57.82 137.1 56.95 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.541 1.163 . . . . 0.0 111.846 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.3 78.02 0.67 Allowed Glycine 0 C--N 1.27 -3.098 0 CA-C-N 112.644 -2.071 . . . . 0.0 109.007 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.773 ' OD2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -107.9 122.23 46.38 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -73.58 112.28 9.52 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 115.101 -2.64 . . . . 0.0 105.425 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG12 ' HB3' ' A' ' 70' ' ' ARG . 17.5 m -123.31 166.75 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' CZ ' ' OE1' ' A' ' 8' ' ' GLU . 35.1 ttt180 -96.53 115.17 26.99 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 24' ' ' VAL . 1.9 t -100.88 131.86 47.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.366 -0.934 . . . . 0.0 112.813 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -106.52 119.42 39.23 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.68 144.7 25.16 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.738 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.6 p -107.42 147.97 36.28 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.311 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.88 -23.31 75.83 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.591 1.528 . . . . 0.0 111.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -67.45 -33.21 74.68 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.632 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 m-20 -170.95 81.4 0.08 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -43.44 -37.12 2.23 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.669 -0.813 . . . . 0.0 111.429 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.0 -4.55 0.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.623 -1.231 . . . . 0.0 109.212 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' LEU . 16.6 mttm -130.18 144.02 51.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.336 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.98 -171.89 31.78 Favored Glycine 0 C--O 1.192 -2.487 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.97 162.19 29.21 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.853 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 68' ' ' THR . 10.2 mt -104.8 138.53 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.013 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.1 p -162.16 87.2 0.63 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.669 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 58.5 t80 116.23 116.87 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 O-C-N 126.04 2.087 . . . . 0.0 109.627 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.772 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -145.91 156.83 43.8 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.479 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.91 152.32 47.26 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.579 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.732 ' NH2' ' HE ' ' A' ' 70' ' ' ARG . 22.3 mtt85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 116.244 -1.836 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.838 0.351 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -58.67 160.11 5.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.672 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -156.67 -178.15 7.14 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 53.31 87.25 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' OD1' ' CE2' ' A' ' 7' ' ' PHE . 3.1 p30 -164.94 151.27 10.31 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.898 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.5 m -81.3 -179.28 7.29 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CE2' ' OD1' ' A' ' 5' ' ' ASP . 74.5 m-85 -146.3 166.67 25.61 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.502 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -126.09 136.36 52.81 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.503 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 tpt -160.68 134.24 6.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.632 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 12.3 mt-10 -80.27 149.71 30.27 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.824 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.19 167.24 36.05 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.748 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 24' ' ' VAL . 8.8 m -99.78 152.38 20.18 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.942 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLY . 69.4 t -105.08 107.45 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' CG1' HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -151.8 84.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 C-N-CA 117.952 -1.499 . . . . 0.0 110.657 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 1.8 m-20 172.14 136.63 0.03 OUTLIER 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.441 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -108.18 147.05 31.85 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.024 -1.071 . . . . 0.0 111.844 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 17' ' ' LEU . 43.7 mt -132.18 170.98 9.93 Favored Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.926 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.7 Cg_endo -96.76 161.88 1.11 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 120.506 0.804 . . . . 0.0 111.066 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 76.96 27.91 0.68 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 2.4 m 65.56 62.93 0.64 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.48 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 2.6 mmt -137.4 165.78 25.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.161 -1.015 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CG ' ' C ' ' A' ' 21' ' ' MET . 3.1 m-85 -152.29 160.5 43.33 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.708 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.36 143.52 45.88 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 55' ' ' VAL . 14.6 p -118.7 139.81 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.851 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -98.49 132.46 43.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.969 1.366 . . . . 0.0 113.652 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' C ' ' H ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -126.41 34.69 4.78 Favored 'General case' 0 C--N 1.26 -3.309 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.912 ' C ' ' H ' ' A' ' 29' ' ' GLY . 11.7 pt-20 -37.19 -4.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.913 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.717 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.8 m120 -70.97 25.64 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.912 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.96 -8.36 18.95 Favored Glycine 0 CA--C 1.559 2.799 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.495 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-70 -124.88 138.91 54.23 Favored 'General case' 0 N--CA 1.513 2.721 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.25 137.16 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.632 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.86 HG12 ' H ' ' A' ' 33' ' ' THR . 8.3 t -148.4 176.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 117.554 -1.658 . . . . 0.0 113.431 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.86 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.2 m -112.87 133.88 54.65 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.544 -1.662 . . . . 0.0 107.442 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.97 176.62 7.91 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.983 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 20' ' ' THR . 40.0 t-80 -148.67 144.19 26.99 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.4 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -87.53 129.11 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 m -65.29 172.59 3.05 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.705 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.8 -18.77 72.05 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.418 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.31 -57.09 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.98 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.8 mmt -64.92 -19.4 65.91 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.797 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -73.28 -50.66 21.0 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -81.46 -27.7 34.49 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.688 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.598 HD22 ' N ' ' A' ' 43' ' ' ASN . 1.3 m120 -86.71 9.09 19.89 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.375 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -170.67 139.93 1.63 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.326 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 46' ' ' ARG . 0.6 OUTLIER -49.57 168.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.87 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.494 ' N ' HG23 ' A' ' 45' ' ' ILE . 30.4 mtp-105 -54.51 166.03 0.49 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 51' ' ' ASP . 32.3 mt -94.3 142.89 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.037 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.8 mp -85.97 172.64 10.52 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.486 HG22 ' CG1' ' A' ' 14' ' ' VAL . 85.8 m -76.15 128.17 34.41 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.51 1.148 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.4 77.43 0.71 Allowed Glycine 0 C--N 1.266 -3.345 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -108.64 122.16 46.52 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 113.237 -1.482 . . . . 0.0 107.535 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -73.52 112.63 9.78 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 114.937 -2.705 . . . . 0.0 104.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 70' ' ' ARG . 18.8 m -124.38 167.17 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttt85 -99.33 113.64 26.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.862 HG21 HG11 ' A' ' 24' ' ' VAL . 3.6 t -100.68 150.24 5.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.814 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -122.58 120.39 33.65 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.256 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.476 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.3 mp -94.45 146.3 24.18 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.334 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -105.07 144.3 28.47 Favored Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.3 -21.3 71.38 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.435 1.423 . . . . 0.0 111.325 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' C ' ' CG ' ' A' ' 61' ' ' ASP . 2.6 t80 -67.79 -23.4 65.2 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.661 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 171.86 81.99 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.774 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -42.15 -24.67 0.05 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.256 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 61' ' ' ASP . 97.2 p -56.59 -3.28 0.1 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.011 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.0 mttm -138.77 145.51 40.26 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.33 -172.35 28.55 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -134.38 159.75 40.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.154 -1.018 . . . . 0.0 110.293 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 68' ' ' THR . 17.8 mt -104.27 137.67 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.555 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.2 p -162.89 87.15 0.57 Allowed 'General case' 0 C--O 1.211 -0.974 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.2 t80 119.7 123.17 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.946 2.029 . . . . 0.0 109.646 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.832 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -154.37 157.36 38.44 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.971 -179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.35 155.55 49.25 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.287 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.008 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 mtt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.978 0.418 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.55 -165.76 0.22 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.964 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -88.97 158.74 17.93 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -144.24 -118.49 0.09 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -153.33 57.15 0.77 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.826 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.22 -177.26 4.06 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.819 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.82 173.03 12.07 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.25 139.1 45.52 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.808 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 9.3 tpt -160.79 147.99 15.54 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.005 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.82 145.81 24.12 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.04 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.57 -179.37 30.62 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 24' ' ' VAL . 48.5 m -113.96 151.33 32.49 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.592 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 50' ' ' GLY . 98.1 t -106.24 107.1 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.478 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 83.27 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.932 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.653 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 16.1 t70 173.2 138.87 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.388 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 105.28 8.37 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.383 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 17' ' ' LEU . 36.5 mt -94.69 171.23 6.95 Favored Pre-proline 0 C--N 1.309 -1.158 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.417 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 18.6 Cg_endo -97.37 161.43 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.161 0.574 . . . . 0.0 111.121 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.46 23.15 0.39 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.27 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.465 ' CG2' ' NE2' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 75.51 61.08 0.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.117 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.44 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 5.4 mmt -145.74 152.77 40.1 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.318 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -149.2 160.9 42.96 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.359 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.653 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 5.0 ttp180 -107.61 132.99 52.69 Favored 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.822 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 24' ' ' VAL . 14.7 p -110.75 130.7 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.206 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -93.22 126.43 38.33 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.601 -1.24 . . . . 0.0 113.811 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.79 HD12 HG23 ' A' ' 32' ' ' VAL . 34.2 mt -114.46 36.04 3.95 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.863 ' C ' ' H ' ' A' ' 29' ' ' GLY . 15.3 pt-20 -36.88 -3.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 111.928 -2.396 . . . . 0.0 112.788 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.733 ' H ' ' C ' ' A' ' 26' ' ' LEU . 19.4 m-20 -70.74 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.863 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.08 -14.02 16.5 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-N 113.365 -1.743 . . . . 0.0 110.836 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' A' ' 26' ' ' LEU . 23.6 t60 -125.13 154.21 41.8 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.52 141.31 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.79 HG23 HD12 ' A' ' 26' ' ' LEU . 2.1 t -148.65 167.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 117.64 -1.624 . . . . 0.0 112.472 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.569 ' H ' HG12 ' A' ' 32' ' ' VAL . 51.8 m -110.42 140.8 44.3 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.863 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.65 175.99 11.42 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 36' ' ' ILE . 14.3 t-80 -126.2 130.57 51.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.22 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' O ' ' ND1' ' A' ' 35' ' ' HIS . 14.0 tt -65.62 159.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 118.93 -1.108 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -80.91 -160.76 0.34 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.834 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -80.19 -5.28 89.75 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -44.39 -24.6 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' TYR . 4.3 mtp -80.19 -33.82 37.96 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.258 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' GLY . 5.9 ttp180 -61.69 -36.82 81.97 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -75.58 -48.75 20.98 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' ND2' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -76.54 -39.53 52.61 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.306 -0.957 . . . . 0.0 110.983 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER 69.0 35.08 2.91 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.807 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 HD12 ' ND2' ' A' ' 43' ' ' ASN . 56.0 mt -145.57 129.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.75 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -46.47 139.98 4.59 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.776 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.2 tp -80.37 143.3 12.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.437 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 28.3 tp -62.32 126.7 28.25 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.697 HG22 HG13 ' A' ' 14' ' ' VAL . 65.0 m -49.68 141.71 9.43 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.728 1.252 . . . . 0.0 111.733 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.68 78.16 0.68 Allowed Glycine 0 C--N 1.264 -3.431 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.683 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.02 121.42 44.78 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 113.064 -1.568 . . . . 0.0 106.986 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -73.04 112.85 9.44 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 114.919 -2.712 . . . . 0.0 104.401 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 70' ' ' ARG . 9.1 m -124.28 171.74 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 120.48 38.2 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.279 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.8 t -101.29 142.69 15.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -118.31 120.18 36.86 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -94.12 144.66 25.3 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.645 -1.222 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -98.26 144.13 27.53 Favored Pre-proline 0 C--N 1.303 -1.431 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.425 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.89 -10.06 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.54 1.493 . . . . 0.0 111.359 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -84.18 -36.38 22.87 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -168.74 87.28 0.19 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.076 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.8 mp -42.14 -29.57 0.24 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.0 t -56.59 -2.22 0.07 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.28 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 62' ' ' LEU . 6.3 mttm -136.43 145.02 44.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.88 -171.47 32.1 Favored Glycine 0 C--O 1.2 -2.023 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.03 163.71 28.95 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.905 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 53' ' ' VAL . 38.5 mt -103.89 140.65 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.395 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.552 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -162.7 87.8 0.6 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.581 -1.248 . . . . 0.0 110.158 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.552 ' CB ' ' O ' ' A' ' 68' ' ' THR . 46.2 t80 111.28 124.8 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.872 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.402 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.817 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -151.9 157.74 42.24 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.919 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -133.77 155.42 49.81 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.655 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 116.357 -1.783 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.9 0.381 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m 52.17 87.61 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.09 -96.23 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -120.27 -89.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.582 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.52 20.41 6.31 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.711 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.613 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 25.7 t -65.54 -175.06 0.23 Allowed 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.721 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -159.59 135.35 8.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.32 138.53 43.35 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.02 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.8 tpp -160.78 131.85 5.52 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 10' ' ' GLU . 38.1 mt-10 -67.77 147.12 53.02 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.83 166.85 35.69 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.7 m -105.52 152.73 22.69 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.089 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 50' ' ' GLY . 22.3 t -105.67 102.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.41 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.86 86.01 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 118.041 -1.464 . . . . 0.0 110.126 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 8.5 t70 173.03 139.39 0.03 OUTLIER 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 112.182 -2.281 . . . . 0.0 107.612 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -120.42 119.56 33.39 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.682 -1.207 . . . . 0.0 112.384 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.2 mt -111.77 174.07 2.53 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.688 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 18.2 Cg_endo -95.8 154.17 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 N-CA-C 110.213 -0.726 . . . . 0.0 110.213 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 1.0 OUTLIER 78.82 48.36 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 19' ' ' ASN . 1.6 t 45.68 58.48 4.26 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.107 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.543 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 5.7 mtt -130.96 155.96 45.91 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.578 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 21' ' ' MET . 16.5 m-85 -155.11 159.47 40.23 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.057 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.671 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 9.4 ttm180 -98.91 131.49 44.95 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 118.436 -1.305 . . . . 0.0 109.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.876 HG11 HG21 ' A' ' 55' ' ' VAL . 11.6 t -105.63 132.14 53.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.66 125.9 47.11 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.677 1.227 . . . . 0.0 113.691 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.702 ' C ' ' H ' ' A' ' 28' ' ' ASN . 96.7 mt -117.96 35.33 4.77 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 103.082 -2.933 . . . . 0.0 103.082 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.2 mt-10 -36.85 -7.44 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.241 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -70.93 25.87 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.14 -12.47 16.91 Favored Glycine 0 CA--C 1.559 2.801 0 CA-C-N 113.659 -1.609 . . . . 0.0 111.195 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.1 m-70 -124.52 153.24 42.36 Favored 'General case' 0 N--CA 1.515 2.807 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.1 t -131.74 138.96 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.622 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -149.45 168.86 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 117.687 -1.605 . . . . 0.0 112.767 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.1 m -112.98 112.81 24.54 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.346 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -109.3 -179.93 3.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.04 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.522 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 6.3 p-80 -161.15 152.52 18.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.76 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' H ' HG22 ' A' ' 36' ' ' ILE . 6.1 tt -79.72 119.66 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.322 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -58.26 -167.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.905 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -45.7 -14.93 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 37' ' ' SER . 64.4 tttt -45.57 -32.09 2.14 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.93 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.56 ' O ' ' N ' ' A' ' 44' ' ' TYR . 2.9 ptt? -67.94 -36.36 80.0 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.304 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttp180 -61.96 -31.91 72.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.806 -1.158 . . . . 0.0 109.366 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.46 -41.83 10.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.537 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -99.87 19.38 16.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.021 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 40' ' ' MET . 1.8 t80 54.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.739 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.4 mt -86.23 83.64 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -145.94 106.43 4.07 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.324 -0.951 . . . . 0.0 111.347 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.4 tt -134.56 146.99 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 48' ' ' LEU . 5.9 tp -92.39 145.63 24.32 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.721 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.2 m -76.56 135.63 39.26 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.286 1.041 . . . . 0.0 111.689 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 77.26 0.71 Allowed Glycine 0 C--N 1.274 -2.872 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -110.45 120.23 41.74 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 113.543 -1.328 . . . . 0.0 108.735 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -76.7 113.62 14.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.709 HG21 HG12 ' A' ' 67' ' ' ILE . 15.5 m -133.77 -178.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -102.71 120.84 41.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.234 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.876 HG21 HG11 ' A' ' 24' ' ' VAL . 7.9 t -100.6 125.76 54.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.6 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -102.15 125.17 48.77 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 7' ' ' PHE . 21.8 mt -93.37 140.74 29.23 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.761 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.3 p -98.57 145.93 30.73 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.287 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 -11.71 11.79 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -75.17 -43.23 53.37 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.735 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 64' ' ' LYS . 3.8 t70 -172.82 94.62 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.031 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.7 mp -41.24 -32.11 0.26 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.624 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -55.97 -7.07 0.28 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.723 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 62' ' ' LEU . 31.5 mmtm -131.29 144.39 51.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.925 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.93 -172.25 31.18 Favored Glycine 0 C--N 1.289 -2.081 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 168.42 18.19 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.709 HG12 HG21 ' A' ' 53' ' ' VAL . 43.5 mt -102.24 140.62 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.577 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -161.41 86.45 0.67 Allowed 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.077 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' THR . 52.6 t80 118.03 126.59 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 CA-C-N 111.921 -2.4 . . . . 0.0 108.459 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CB ' HG12 ' A' ' 53' ' ' VAL . 22.0 ptt-85 -134.85 156.66 48.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 119.345 -0.942 . . . . 0.0 113.126 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.09 47.72 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptt? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.853 0.359 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -55.39 -13.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -75.8 134.72 40.33 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.74 101.6 2.93 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.799 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -160.69 -44.41 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.846 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -166.58 179.95 5.2 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 57' ' ' LEU . 82.9 m-85 -135.37 129.73 33.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.763 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 12.1 pt-20 -94.99 139.92 30.69 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.444 ' SD ' HD22 ' A' ' 26' ' ' LEU . 24.8 ttm -160.34 127.14 4.3 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.619 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.0 146.27 53.71 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.372 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.2 159.96 30.85 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.541 ' C ' HG23 ' A' ' 24' ' ' VAL . 49.9 m -98.06 148.79 23.16 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 50' ' ' GLY . 40.0 t -105.28 106.15 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.38 83.58 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 C-N-CA 117.891 -1.523 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.54 ' OD1' ' CD2' ' A' ' 17' ' ' LEU . 0.1 OUTLIER 171.07 131.49 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.885 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' O ' HD22 ' A' ' 17' ' ' LEU . 1.8 t -108.77 136.8 47.73 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.557 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' CD2' ' OD1' ' A' ' 15' ' ' ASP . 3.1 mm? -114.41 154.65 46.45 Favored Pre-proline 0 N--CA 1.487 1.389 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.393 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.521 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 37.2 Cg_endo -98.09 118.98 0.13 Allowed 'Trans proline' 0 C--O 1.206 -1.117 0 C-N-CA 120.156 0.571 . . . . 0.0 111.112 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER 132.32 24.02 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 O-C-N 125.453 1.721 . . . . 0.0 107.789 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.421 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.6 m 74.53 53.09 0.09 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.283 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.519 ' HB2' HD21 ' A' ' 19' ' ' ASN . 26.2 mtt -143.95 166.24 25.51 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.625 -1.23 . . . . 0.0 112.008 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -146.54 166.06 27.6 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.037 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.51 139.69 52.53 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.067 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 55' ' ' VAL . 9.9 p -116.22 139.76 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.172 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.34 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -96.34 124.36 40.31 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.783 1.278 . . . . 0.0 113.564 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.696 ' O ' ' N ' ' A' ' 28' ' ' ASN . 73.3 mt -113.25 34.76 4.3 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 101.858 -3.386 . . . . 0.0 101.858 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 2.5 pp20? -36.76 -5.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.017 -2.356 . . . . 0.0 112.777 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 26' ' ' LEU . 27.6 t-20 -70.93 25.95 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.88 -13.75 14.45 Favored Glycine 0 CA--C 1.56 2.904 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' A' ' 31' ' ' VAL . 1.9 t60 -124.84 151.95 44.59 Favored 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' N ' ' ND1' ' A' ' 30' ' ' HIS . 1.0 OUTLIER -130.51 142.54 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -148.8 174.45 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.388 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.742 ' H ' HG12 ' A' ' 32' ' ' VAL . 65.9 m -119.69 132.47 55.67 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.28 179.87 6.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 118.452 -1.299 . . . . 0.0 112.252 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.556 ' C ' ' CD2' ' A' ' 35' ' ' HIS . 4.3 p-80 -144.01 157.21 44.48 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.8 tt -90.63 133.57 32.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.061 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . 9.2 t -52.28 173.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.015 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.94 -9.44 1.32 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.732 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' SER . 35.7 mmtm -45.62 -37.02 5.19 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.579 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.575 ' CG ' ' N ' ' A' ' 41' ' ' ARG . 14.7 ptm -64.85 -41.52 95.63 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.49 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' N ' ' CG ' ' A' ' 40' ' ' MET . 7.4 ttm-85 -55.83 -41.69 74.64 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.457 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -81.05 -43.42 19.57 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.63 14.43 3.14 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 52.92 -159.5 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.296 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 45' ' ' ILE . 8.2 mt -51.3 123.51 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.589 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 9.3 tpp180 -155.48 87.02 1.09 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.312 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.485 HD13 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -133.71 144.62 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.25 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 47' ' ' ILE . 10.9 tp -152.46 121.4 6.58 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.8 t -69.58 130.42 42.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 122.778 1.275 . . . . 0.0 111.327 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.55 77.58 0.71 Allowed Glycine 0 C--N 1.266 -3.315 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.834 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 94.0 m-20 -109.07 117.54 34.43 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.613 -1.294 . . . . 0.0 108.182 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.8 mttp -75.53 112.67 12.1 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 115.424 -2.51 . . . . 0.0 104.572 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' A' ' 67' ' ' ILE . 20.9 m -134.17 179.41 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.201 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.33 118.71 37.52 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.954 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 HG11 ' A' ' 24' ' ' VAL . 3.1 t -101.34 141.4 17.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.674 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -118.11 115.21 24.35 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.752 HD12 ' H ' ' A' ' 57' ' ' LEU . 1.9 mp -93.92 159.2 15.28 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.966 -1.093 . . . . 0.0 110.134 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -121.8 143.51 38.57 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.856 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.64 -25.1 77.9 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.536 1.491 . . . . 0.0 111.327 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -65.22 -34.08 77.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.063 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 64' ' ' LYS . 28.9 t0 -172.44 75.6 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LYS . 26.4 mt -42.56 -28.95 0.25 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.314 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 m -56.22 -5.46 0.19 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.568 -1.253 . . . . 0.0 108.692 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' LEU . 30.7 mttp -130.24 145.73 51.78 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.67 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.8 30.44 Favored Glycine 0 C--O 1.199 -2.049 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -134.33 161.56 34.62 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.936 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.559 HG23 ' HB ' ' A' ' 53' ' ' VAL . 39.0 mt -104.27 141.5 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.436 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.09 86.05 0.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.479 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 70.8 t80 126.15 133.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 111.798 -2.456 . . . . 0.0 107.993 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -137.83 153.18 49.65 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.243 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.26 149.29 41.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.66 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 116.325 -1.797 . . . . 0.0 110.842 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.899 0.381 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -153.74 -10.28 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.765 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -151.72 -154.58 0.55 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.848 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.59 -94.4 0.13 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 t70 53.88 27.37 7.14 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.689 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -97.83 175.65 6.08 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.814 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -118.73 137.71 53.16 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.36 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -89.16 139.41 30.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.197 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' VAL . 6.7 tpt -160.51 139.15 10.25 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.378 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.41 149.95 20.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.12 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.88 160.89 34.2 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.775 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 24' ' ' VAL . 30.5 m -100.01 153.18 19.41 Favored 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.415 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 50' ' ' GLY . 59.8 t -105.46 103.61 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.3 84.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.674 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 172.74 145.13 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 112.554 -2.112 . . . . 0.0 108.507 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 111.51 18.62 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.377 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 17' ' ' LEU . 26.0 mt -95.89 169.66 8.79 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.088 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 23.7 Cg_endo -96.63 162.78 1.14 Allowed 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 120.713 0.942 . . . . 0.0 110.699 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER 78.68 27.71 0.46 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.995 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m 68.83 61.62 0.34 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.488 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 57.8 mtm -147.22 167.2 24.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.572 -1.251 . . . . 0.0 111.64 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m-85 -147.25 161.87 40.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.182 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 31.8 ttm-85 -112.46 138.48 49.16 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 118.792 -1.163 . . . . 0.0 111.118 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 12' ' ' THR . 14.2 p -112.34 134.57 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -97.62 126.9 43.19 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.211 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' ASN . 1.1 mp -112.07 37.35 3.01 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 103.074 -2.936 . . . . 0.0 103.074 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.852 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 tp10 -35.84 -10.19 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 112.64 -2.073 . . . . 0.0 111.881 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' LEU . 1.6 p-10 -70.69 25.95 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.852 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.04 -15.6 13.45 Favored Glycine 0 CA--C 1.566 3.262 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.976 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 26' ' ' LEU . 6.0 m-70 -124.44 153.59 41.73 Favored 'General case' 0 N--CA 1.522 3.16 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 31' ' ' VAL . 6.0 p -131.34 135.26 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 114.558 -1.201 . . . . 0.0 107.885 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.768 HG12 ' N ' ' A' ' 33' ' ' THR . 86.6 t -150.13 171.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 117.855 -1.538 . . . . 0.0 111.908 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.768 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -110.59 142.85 41.87 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.586 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -144.09 169.51 17.71 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.736 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.466 ' CD2' ' H ' ' A' ' 36' ' ' ILE . 8.3 t-80 -143.33 152.37 41.55 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.443 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 5.1 tt -103.79 154.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.389 -0.925 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 38' ' ' GLY . 39.8 t -82.41 -162.27 0.55 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.402 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -69.33 -14.36 68.91 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.149 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -51.15 -17.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.361 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.457 ' SD ' ' HG2' ' A' ' 46' ' ' ARG . 12.3 ttp -75.37 -43.45 50.3 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.044 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -64.63 -32.43 74.09 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.433 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' ' CE1' ' A' ' 44' ' ' TYR . 39.1 mmtm -76.67 -34.2 58.24 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.523 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -77.3 17.16 0.51 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.683 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' TYR . 0.8 OUTLIER 60.4 -151.63 0.4 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.728 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 44' ' ' TYR . 63.4 mt -42.24 145.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' HG2' ' SD ' ' A' ' 40' ' ' MET . 43.4 mtt85 -73.63 155.14 39.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.335 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CG1' ' NH2' ' A' ' 70' ' ' ARG . 11.5 mm -75.02 148.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.541 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 48' ' ' LEU . 4.4 mm? -57.21 152.27 14.08 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.554 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -45.49 150.37 0.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 122.683 1.23 . . . . 0.0 111.734 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 81.55 80.75 0.89 Allowed Glycine 0 C--N 1.263 -3.487 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 66.8 m-20 -106.68 118.52 36.88 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.38 113.71 15.45 Favored 'General case' 0 C--N 1.278 -2.533 0 C-N-CA 115.935 -2.306 . . . . 0.0 105.246 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 67' ' ' ILE . 1.7 m -138.58 176.07 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 117.889 -1.525 . . . . 0.0 113.684 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.568 HH21 ' CB ' ' A' ' 69' ' ' TYR . 20.6 ttm180 -96.56 120.49 36.98 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.413 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 9' ' ' MET . 0.5 OUTLIER -100.8 133.8 42.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.889 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -107.59 131.85 53.91 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -93.29 128.99 39.52 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.341 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 61' ' ' ASP . 71.1 p -66.32 155.93 86.66 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.74 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -42.68 -21.61 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.183 1.255 . . . . 0.0 110.756 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -82.62 -36.96 25.64 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.785 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 58' ' ' THR . 45.0 t0 44.59 38.78 2.88 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.455 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -95.85 -66.4 0.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.297 -1.361 . . . . 0.0 110.855 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 62' ' ' LEU . 43.7 t -137.4 0.14 2.26 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.827 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -120.01 149.7 41.73 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.501 1.143 . . . . 0.0 113.923 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.9 -172.39 23.34 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -137.51 160.79 38.13 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.537 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 53' ' ' VAL . 11.0 mt -103.73 132.14 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.539 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.32 86.17 0.52 Allowed 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.024 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.568 ' CB ' HH21 ' A' ' 54' ' ' ARG . 77.7 t80 127.56 71.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.97 0 CA-C-N 112.502 -2.136 . . . . 0.0 108.763 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.548 ' NH2' ' CG1' ' A' ' 47' ' ' ILE . 15.5 ttp180 -82.7 146.4 29.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.091 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.22 152.41 43.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.717 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.835 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' C ' ' HG ' ' A' ' 2' ' ' SER . 5.2 ptm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.961 0.41 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HG ' ' C ' ' A' ' 1' ' ' MET . 59.8 p 42.3 -138.82 0.19 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.709 -0.797 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 2' ' ' SER . 15.8 tptt -127.45 168.71 14.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 6' ' ' SER . 18.0 pt-20 -85.99 -143.47 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.26 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 7.0 t70 -78.06 6.78 7.21 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.29 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.486 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 5.7 t -77.54 176.58 8.79 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -141.0 155.34 46.22 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.925 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.94 142.03 51.73 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.208 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.4 tpp -161.25 125.76 3.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.279 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.504 ' CG ' ' NE ' ' A' ' 54' ' ' ARG . 41.1 mp0 -79.89 146.31 32.22 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.158 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.62 -175.9 31.09 Favored Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.77 -1.681 . . . . 0.0 110.336 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -118.44 149.74 40.74 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.4 t -105.62 104.34 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -141.82 84.95 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 CA-C-O 122.959 1.362 . . . . 0.0 109.463 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.672 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 18.6 t70 174.91 137.66 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 112.181 -2.281 . . . . 0.0 107.415 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.9 p -123.26 111.6 16.64 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.512 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.4 mt -100.7 170.39 6.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' O ' ' SD ' ' A' ' 21' ' ' MET . 18.1 Cg_endo -97.1 161.94 1.01 Allowed 'Trans proline' 0 C--O 1.208 -0.978 0 C-N-CA 120.65 0.9 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 0.2 OUTLIER 82.65 15.91 0.38 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 124.037 0.836 . . . . 0.0 109.016 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 79.16 62.13 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.954 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.544 ' SD ' ' O ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -148.18 159.5 43.89 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.136 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' CG ' ' C ' ' A' ' 21' ' ' MET . 2.3 m-85 -151.26 157.6 42.79 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.672 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 15.7 ttm180 -100.36 137.08 39.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.482 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 24' ' ' VAL . 12.0 p -109.57 123.93 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -92.17 140.84 29.22 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 123.256 1.503 . . . . 0.0 113.687 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.738 ' C ' ' H ' ' A' ' 28' ' ' ASN . 68.7 mt -128.14 35.91 4.37 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 102.028 -3.323 . . . . 0.0 102.028 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 7.9 pt-20 -37.44 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 112.261 -2.245 . . . . 0.0 112.39 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.738 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.3 p30 -70.78 26.15 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 117.25 -18.02 12.34 Favored Glycine 0 CA--C 1.568 3.378 0 CA-C-N 113.577 -1.647 . . . . 0.0 111.508 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.7 t60 -124.59 156.46 37.39 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 118.459 1.13 . . . . 0.0 113.634 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.89 146.44 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 33' ' ' THR . 2.9 t -149.24 171.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 118.137 -1.425 . . . . 0.0 111.322 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.685 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m -114.1 146.41 40.31 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.383 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 67' ' ' ILE . . . -154.19 174.91 14.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.027 -1.469 . . . . 0.0 111.721 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -139.37 143.45 37.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.763 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' SER . 9.2 tt -83.88 158.32 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.517 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 36' ' ' ILE . 4.3 m -74.25 -175.18 2.19 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.573 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' ARG . . . -68.93 -4.59 42.23 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -43.43 -27.49 0.27 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 8.5 ttp -83.81 -35.91 23.92 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.437 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.6 ttt180 -65.01 -33.3 75.72 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -82.0 -50.33 9.24 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.64 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' C ' ' N ' ' A' ' 45' ' ' ILE . 16.3 m120 -71.91 -17.7 62.08 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.541 -0.863 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.8 t80 49.2 11.87 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.497 ' N ' ' C ' ' A' ' 43' ' ' ASN . 24.2 mt -155.96 77.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.633 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH1' ' CG ' ' A' ' 46' ' ' ARG . 7.9 tpt85 -155.51 83.06 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.462 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 47' ' ' ILE . 7.3 tp -135.5 105.89 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.207 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.99 121.56 15.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.451 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 14' ' ' VAL . 85.6 m -76.98 141.16 40.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.495 1.141 . . . . 0.0 111.472 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.16 78.83 0.61 Allowed Glycine 0 C--N 1.265 -3.375 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.669 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -108.57 118.84 37.82 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 113.451 -1.374 . . . . 0.0 107.559 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 71' ' ' ALA . 17.9 tttt -75.37 112.43 11.67 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 115.307 -2.557 . . . . 0.0 104.304 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 70' ' ' ARG . 32.6 m -132.47 -178.56 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.504 ' NE ' ' CG ' ' A' ' 10' ' ' GLU . 3.5 mpt_? -101.88 122.56 44.24 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.082 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.26 132.41 48.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.562 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.546 ' OE1' ' NH1' ' A' ' 66' ' ' ARG . 43.9 mt-10 -108.9 114.47 28.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -93.48 149.08 21.51 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.647 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -110.48 148.52 38.63 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.91 -20.82 72.4 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.682 1.588 . . . . 0.0 111.762 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -71.39 -24.57 62.09 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -177.68 74.98 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.721 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.059 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -41.23 -36.34 0.75 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.69 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.4 t -55.1 -4.37 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' LEU . 19.3 mttm -134.68 145.38 48.48 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.052 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' ALA . . . -165.92 -170.83 31.36 Favored Glycine 0 C--O 1.192 -2.531 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' NH1' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -127.4 166.17 18.39 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.024 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 52.1 mt -103.87 141.63 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.299 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -161.47 88.09 0.71 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 118.074 -1.451 . . . . 0.0 111.339 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 34.0 t80 116.78 99.51 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 112.073 -2.331 . . . . 0.0 110.678 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.705 ' HA ' HG12 ' A' ' 53' ' ' VAL . 25.0 ptt-85 -91.8 151.98 20.35 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.186 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -142.98 155.78 44.74 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.428 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 10.1 mmt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.802 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.905 0.383 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.2 6.46 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.962 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -92.72 110.09 21.52 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.953 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 5' ' ' ASP . 9.4 tp10 -148.54 163.74 36.3 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.564 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -93.16 -44.95 8.1 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.028 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -70.25 -177.79 1.51 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.621 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -153.09 130.51 11.36 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.085 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.77 147.16 23.62 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ttm -161.58 127.6 3.73 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.111 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -72.74 147.25 45.79 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.17 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.1 -170.68 23.1 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.354 -1.403 . . . . 0.0 109.888 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 m -124.92 154.99 40.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' ' H ' ' A' ' 51' ' ' ASP . 56.8 t -106.42 106.61 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.841 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG13 ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -150.38 83.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.673 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 27.8 t70 171.67 144.76 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 112.871 -1.968 . . . . 0.0 108.3 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.79 104.4 7.14 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 17' ' ' LEU . 21.8 mt -94.78 168.64 10.88 Favored Pre-proline 0 C--N 1.31 -1.141 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.294 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 17.9 Cg_endo -96.45 162.83 1.2 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 120.665 0.91 . . . . 0.0 109.948 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.34 22.18 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.367 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.474 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 75.33 61.86 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.475 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.572 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 9.8 mtt -150.76 158.42 44.13 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.539 -1.264 . . . . 0.0 111.163 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CD1' ' C ' ' A' ' 21' ' ' MET . 5.4 m-85 -151.54 158.97 44.27 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.673 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 24.2 ttm180 -100.49 131.19 46.54 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 118.008 -1.477 . . . . 0.0 110.066 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 55' ' ' VAL . 2.5 t -108.37 125.94 65.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -93.13 139.89 30.09 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 123.238 1.494 . . . . 0.0 114.514 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.707 ' C ' ' H ' ' A' ' 28' ' ' ASN . 35.4 mt -133.52 35.29 3.42 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.853 ' C ' ' H ' ' A' ' 29' ' ' GLY . 14.9 pt-20 -37.08 -6.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 112.479 -2.146 . . . . 0.0 112.404 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.707 ' H ' ' C ' ' A' ' 26' ' ' LEU . 14.2 p30 -70.62 25.91 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.853 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.53 -12.47 15.85 Favored Glycine 0 CA--C 1.561 2.942 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.059 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' C ' ' A' ' 26' ' ' LEU . 2.1 m-70 -124.84 148.35 48.27 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.65 140.11 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.665 ' CG2' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -147.24 167.29 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 117.621 -1.631 . . . . 0.0 112.715 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.435 ' H ' HG12 ' A' ' 32' ' ' VAL . 94.9 m -109.52 109.16 19.88 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.76 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.85 176.26 5.13 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.168 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -129.16 158.88 37.75 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.7 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 39' ' ' LYS . 14.9 tt -99.9 159.03 3.71 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.984 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -98.29 -159.58 0.75 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.534 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 40' ' ' MET . . . -45.72 -10.91 0.03 OUTLIER Glycine 0 N--CA 1.5 2.911 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.566 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' HD11 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -45.98 -25.07 0.49 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.078 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.453 ' N ' ' C ' ' A' ' 38' ' ' GLY . 8.3 ttm -58.89 -48.84 79.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.075 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -60.87 -25.7 66.87 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.557 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 44' ' ' TYR . 80.6 mttt -95.06 -1.99 51.08 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.91 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.634 ' C ' ' H ' ' A' ' 45' ' ' ILE . 27.4 p-10 -61.32 -0.67 0.4 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.681 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.463 ' H ' ' C ' ' A' ' 42' ' ' LYS . 16.0 t80 -52.98 -10.63 0.18 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 117.935 -1.506 . . . . 0.0 108.089 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 ' H ' ' C ' ' A' ' 43' ' ' ASN . 15.1 mt -150.5 46.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.438 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 46' ' ' ARG . 34.7 ptt-85 -41.29 154.74 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.241 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 tp -101.65 149.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 48' ' ' LEU . 83.0 mt -56.23 166.83 0.75 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.291 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.436 ' OG1' HG13 ' A' ' 14' ' ' VAL . 11.6 t -64.82 150.98 46.57 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.835 1.302 . . . . 0.0 112.337 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 86.77 80.67 1.19 Allowed Glycine 0 C--N 1.266 -3.358 0 CA-C-N 112.208 -2.269 . . . . 0.0 109.838 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -107.16 121.11 43.86 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 115.39 15.83 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 115.623 -2.431 . . . . 0.0 105.687 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 HG12 ' A' ' 67' ' ' ILE . 8.4 m -134.8 173.84 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 118.203 -1.399 . . . . 0.0 114.588 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 ttp180 -95.0 119.67 33.91 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.907 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 24' ' ' VAL . 1.4 t -101.82 120.69 51.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.707 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -97.33 124.7 41.56 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.78 154.09 17.45 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.725 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 HG21 HH21 ' A' ' 66' ' ' ARG . 18.9 p -121.67 148.54 50.88 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.726 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.0 -20.21 35.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.73 1.62 . . . . 0.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 61' ' ' ASP . 22.5 t80 -63.97 -26.88 68.78 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.229 -0.989 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . 0.7 OUTLIER 166.95 95.63 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.907 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.054 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -44.3 -32.27 1.26 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.599 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -57.62 -3.39 0.19 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.166 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' LEU . 10.6 mmtt -131.78 144.19 50.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.114 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.82 -171.67 32.27 Favored Glycine 0 C--O 1.203 -1.815 0 N-CA-C 108.891 -1.683 . . . . 0.0 108.891 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH21 HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -135.2 166.5 22.94 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.002 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.604 HG12 HG21 ' A' ' 53' ' ' VAL . 64.2 mt -103.94 135.31 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.408 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.539 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -163.47 86.92 0.52 Allowed 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.968 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.539 ' CB ' ' O ' ' A' ' 68' ' ' THR . 90.5 t80 126.18 93.37 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 CA-C-N 112.588 -2.096 . . . . 0.0 109.065 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 156.87 17.18 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.81 143.11 33.25 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.993 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 1' ' ' MET . 9.6 mmm . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.888 0.375 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -77.82 -34.12 52.11 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.953 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -94.0 149.67 21.03 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.178 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.47 122.4 2.76 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.6 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 6' ' ' SER . 36.9 t70 -157.95 -117.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.582 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -143.88 162.93 34.83 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.497 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.686 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER 172.72 -172.34 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.495 -1.282 . . . . 0.0 111.502 -179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 6.6 tp10 -91.59 145.75 24.35 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.82 134.87 8.02 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.329 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.12 142.02 33.7 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 -173.03 19.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.01 155.1 33.54 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.882 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 50' ' ' GLY . 61.8 t -106.02 106.52 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -149.79 82.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 117.692 -1.603 . . . . 0.0 110.437 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.6 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 29.7 t0 172.71 140.75 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 113.003 -1.908 . . . . 0.0 108.785 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 3.2 p -125.17 102.73 7.61 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.1 mm? -90.28 170.8 9.53 Favored Pre-proline 0 C--N 1.302 -1.465 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.36 162.89 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 120.617 0.878 . . . . 0.0 110.579 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 78.59 24.11 0.61 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.999 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.463 ' O ' ' SD ' ' A' ' 21' ' ' MET . 1.2 m 71.3 62.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.712 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.463 ' SD ' ' O ' ' A' ' 20' ' ' THR . 10.5 mmt -147.94 160.21 43.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.541 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 2.2 m-85 -148.45 166.66 27.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 3.8 tpp85 -112.96 133.04 55.11 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.531 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.35 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -94.39 117.11 29.62 Favored 'General case' 0 C--N 1.257 -3.418 0 C-N-CA 118.932 -1.107 . . . . 0.0 113.063 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.699 ' C ' ' H ' ' A' ' 28' ' ' ASN . 4.4 mt -110.23 34.74 3.73 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.866 ' C ' ' H ' ' A' ' 29' ' ' GLY . 8.0 pt-20 -37.3 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.674 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -71.03 25.56 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 178.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.866 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.74 -9.78 18.97 Favored Glycine 0 CA--C 1.56 2.847 0 CA-C-N 113.362 -1.744 . . . . 0.0 110.38 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 27.9 m-70 -124.89 151.12 45.75 Favored 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 2.5 p -131.05 136.73 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.754 HG12 ' N ' ' A' ' 33' ' ' THR . 33.6 t -148.2 169.24 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 117.346 -1.741 . . . . 0.0 113.068 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.754 ' N ' HG12 ' A' ' 32' ' ' VAL . 72.4 m -108.1 132.29 53.73 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.192 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.24 175.6 9.12 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 36' ' ' ILE . 1.7 t-80 -142.85 138.39 30.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.035 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.578 HD11 ' HG2' ' A' ' 40' ' ' MET . 12.1 tt -98.22 146.74 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.757 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 p -57.26 166.85 1.04 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.99 -8.57 87.54 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.215 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -46.74 -53.98 10.67 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.634 ' N ' ' SD ' ' A' ' 40' ' ' MET . 0.6 OUTLIER -57.87 -50.97 71.51 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.18 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -45.47 -34.84 3.4 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.313 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -76.0 -29.88 58.34 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.259 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 40' ' ' MET . 11.9 m120 -95.37 15.8 18.52 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.459 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 45' ' ' ILE . 1.3 m-85 42.88 -156.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.034 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 45' ' ' ILE . 14.6 mt 32.31 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.35 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -78.83 170.73 16.22 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.996 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.64 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.55 172.36 0.24 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.817 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -75.34 149.16 38.77 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.392 1.091 . . . . 0.0 111.898 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.6 80.23 0.57 Allowed Glycine 0 C--N 1.27 -3.104 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.318 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 28.9 t0 -107.41 122.95 47.64 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -73.98 113.7 11.45 Favored 'General case' 0 C--N 1.278 -2.539 0 C-N-CA 115.127 -2.629 . . . . 0.0 104.64 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 70' ' ' ARG . 28.4 m -122.99 164.66 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' NH1' ' CD2' ' A' ' 69' ' ' TYR . 17.0 ttm180 -99.5 106.1 18.09 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.87 152.93 5.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.366 -0.934 . . . . 0.0 113.276 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -119.99 122.31 40.88 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.296 -1.32 . . . . 0.0 107.89 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 26.1 mt -94.34 140.31 29.96 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.266 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.5 ' C ' ' OG ' ' A' ' 6' ' ' SER . 32.8 p -96.85 150.64 37.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.113 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' OG ' ' A' ' 6' ' ' SER . 1.8 Cg_endo -63.91 -26.12 67.02 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 121.672 1.581 . . . . 0.0 111.54 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 55.7 m-85 -58.21 -29.24 65.53 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.028 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.4 OUTLIER 167.47 94.77 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.51 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.012 ' H ' HD12 ' A' ' 62' ' ' LEU . 3.9 mp -44.63 -16.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.635 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -56.64 -8.55 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.949 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -135.91 148.48 48.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.235 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.55 -172.55 32.16 Favored Glycine 0 C--O 1.205 -1.696 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -135.29 157.53 46.66 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.737 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 53' ' ' VAL . 15.7 mt -104.33 140.22 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.278 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -163.94 86.42 0.49 Allowed 'General case' 0 C--O 1.208 -1.1 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.209 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.544 ' CB ' ' O ' ' A' ' 68' ' ' THR . 64.9 t80 122.59 126.63 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.222 0 O-C-N 125.902 2.001 . . . . 0.0 108.927 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.806 ' HB3' HG12 ' A' ' 53' ' ' VAL . 6.0 ptt85 -139.61 156.42 46.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 118.87 -1.132 . . . . 0.0 113.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.01 150.86 46.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.899 0.381 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -151.67 -99.78 0.06 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.742 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -80.95 100.55 8.98 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 6' ' ' SER . 4.6 tm-20 -144.39 -40.42 0.27 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.878 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.72 23.76 0.23 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.756 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 4' ' ' GLU . 58.4 m -156.94 162.75 39.62 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -110.59 129.79 55.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.482 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -89.83 131.27 35.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -160.77 133.4 6.25 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.776 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -79.32 149.22 31.82 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.72 -178.51 29.11 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.296 -1.43 . . . . 0.0 109.74 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 150.86 38.26 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.813 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLY . 60.4 t -105.04 105.79 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.927 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.701 HG13 HG22 ' A' ' 49' ' ' THR . 0.4 OUTLIER -150.64 82.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 C-N-CA 116.882 -1.927 . . . . 0.0 112.908 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 167.69 149.14 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 113.455 -1.702 . . . . 0.0 107.726 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.7 p -133.06 129.25 37.79 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.252 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.6 mt -113.44 153.91 45.58 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.477 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.633 ' C ' ' ND2' ' A' ' 19' ' ' ASN . 36.8 Cg_endo -97.14 117.42 0.14 Allowed 'Trans proline' 0 C--O 1.209 -0.946 0 O-C-N 122.318 0.641 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.797 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER 143.39 14.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 125.257 1.598 . . . . 0.0 107.543 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 1.1 m 80.47 50.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.715 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.2 mmt -141.55 161.67 37.36 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.249 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' ALA . 37.5 m-85 -143.71 150.45 38.67 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.578 HH11 ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -100.4 135.22 42.16 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.066 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 55' ' ' VAL . 2.4 t -107.58 130.03 60.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.925 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -93.63 121.94 35.57 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.703 -1.199 . . . . 0.0 113.966 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.716 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.4 mt -110.96 36.02 3.31 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.869 ' C ' ' H ' ' A' ' 29' ' ' GLY . 17.6 pt-20 -36.67 -7.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 112.904 -1.953 . . . . 0.0 112.163 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.716 ' N ' ' O ' ' A' ' 26' ' ' LEU . 4.3 m-20 -70.88 25.69 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.29 -13.61 16.1 Favored Glycine 0 CA--C 1.561 2.96 0 CA-C-N 113.761 -1.563 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.6 m-70 -124.66 159.07 31.62 Favored 'General case' 0 N--CA 1.513 2.716 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' HH11 ' A' ' 23' ' ' ARG . 1.4 p -130.7 146.5 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG12 ' H ' ' A' ' 33' ' ' THR . 2.1 t -147.78 176.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 117.553 -1.659 . . . . 0.0 113.554 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.793 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.1 m -119.11 102.54 8.8 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.689 -1.596 . . . . 0.0 108.602 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 22' ' ' PHE . . . -96.32 174.73 6.73 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 118.961 -1.096 . . . . 0.0 112.224 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.17 137.66 36.24 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.129 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 36' ' ' ILE . 20.3 tt -90.61 133.61 31.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.292 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -44.9 154.23 0.15 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.429 -0.909 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.42 -27.37 73.62 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.424 -1.369 . . . . 0.0 110.412 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -45.99 -46.27 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.728 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 mmt -63.69 -52.77 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.674 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 41' ' ' ARG . 2.8 ttp180 -49.29 -58.24 5.41 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.788 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -50.59 -38.21 44.19 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.696 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.654 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 1.5 t-20 -94.53 16.84 14.37 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.833 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.654 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 24.0 p90 33.33 56.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.336 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 46' ' ' ARG . 23.7 mm -99.1 155.94 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.231 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' N ' HG22 ' A' ' 45' ' ' ILE . 2.1 ptm180 -138.67 152.41 48.03 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.57 148.45 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.12 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 48' ' ' LEU . 30.3 tp -56.99 139.18 52.95 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 14' ' ' VAL . 66.1 m -56.32 141.88 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.524 1.154 . . . . 0.0 111.078 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.33 78.57 0.64 Allowed Glycine 0 C--N 1.266 -3.306 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.045 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.636 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -108.42 127.94 54.34 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -72.94 113.31 9.83 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 114.691 -2.804 . . . . 0.0 104.631 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.827 HG12 ' HB3' ' A' ' 70' ' ' ARG . 26.9 m -118.56 162.67 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 69' ' ' TYR . 52.2 ttp180 -92.44 117.71 30.21 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 24' ' ' VAL . 1.3 t -100.49 147.95 7.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.155 -1.018 . . . . 0.0 113.081 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -120.08 112.35 19.01 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.28 146.68 23.53 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.385 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.4 p -102.47 136.97 19.27 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.27 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.1 -18.98 46.63 Favored 'Trans proline' 0 C--O 1.216 -0.588 0 C-N-CA 121.363 1.375 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -71.53 -32.47 68.2 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.629 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.3 m-20 -172.54 77.8 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.513 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.693 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.4 mp -39.84 -28.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.385 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' ASP . 35.8 p -56.47 -3.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.406 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 62' ' ' LEU . 24.3 mmtt -134.76 144.38 47.67 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.961 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.49 -172.62 31.2 Favored Glycine 0 C--N 1.295 -1.697 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -135.01 164.29 27.95 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 68' ' ' THR . 19.7 mt -103.6 134.85 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.8 p -162.34 86.55 0.6 Allowed 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.596 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' CB ' ' O ' ' A' ' 68' ' ' THR . 54.9 t80 113.67 122.91 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.182 0 O-C-N 125.965 2.041 . . . . 0.0 109.485 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.827 ' HB3' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.25 157.16 43.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.847 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.71 156.14 47.56 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.647 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 . . . . . 0 C--N 1.306 -1.306 0 CA-C-O 116.376 -1.774 . . . . 0.0 110.733 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -151.23 40.26 0.69 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.831 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.07 -45.06 95.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.967 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -150.32 170.84 18.06 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.434 -0.906 . . . . 0.0 111.001 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 2.6 m-20 -101.58 -170.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.173 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.33 178.36 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.706 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.749 ' HB3' HD12 ' A' ' 57' ' ' LEU . 3.2 t80 -153.63 144.1 22.41 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.927 -1.109 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -106.68 129.29 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.903 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.6 tpt -160.71 131.23 5.31 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.352 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -76.76 155.3 33.28 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.822 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.07 173.46 37.52 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.19 154.75 21.3 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.072 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 50' ' ' GLY . 45.7 t -105.4 102.95 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.537 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.24 83.86 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 117.726 -1.59 . . . . 0.0 110.263 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 64.0 t0 172.01 138.8 0.03 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 111.947 -2.388 . . . . 0.0 107.892 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' THR . 1.3 t -116.21 105.44 12.57 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 33' ' ' THR . 14.9 mt -92.39 173.0 5.53 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.706 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.7 Cg_endo -97.04 158.86 1.06 Allowed 'Trans proline' 0 C--O 1.212 -0.792 0 C-N-CA 120.297 0.665 . . . . 0.0 110.905 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 80.08 24.76 0.38 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.356 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER 71.81 60.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.092 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.604 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 42.2 mtt -140.73 167.21 22.71 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.596 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.4 m-85 -156.39 160.22 39.44 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.801 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.69 ' H ' ' HB3' ' A' ' 15' ' ' ASP . 19.3 ttm-85 -97.42 134.72 40.3 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.234 -1.386 . . . . 0.0 109.274 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 55' ' ' VAL . 14.7 t -105.69 125.75 61.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -94.15 124.12 37.96 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 118.896 -1.122 . . . . 0.0 114.015 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' C ' ' H ' ' A' ' 28' ' ' ASN . 47.5 mt -115.5 36.05 4.13 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.864 ' C ' ' H ' ' A' ' 29' ' ' GLY . 1.0 OUTLIER -36.64 -7.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 112.428 -2.169 . . . . 0.0 112.179 -179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.719 ' H ' ' C ' ' A' ' 26' ' ' LEU . 5.4 t-20 -70.81 26.04 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.864 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.8 -14.93 14.24 Favored Glycine 0 CA--C 1.564 3.151 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.455 ' O ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-70 -124.89 155.71 39.09 Favored 'General case' 0 N--CA 1.517 2.878 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.26 139.23 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.909 HG12 ' H ' ' A' ' 33' ' ' THR . 13.6 t -148.85 177.22 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.934 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.909 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.4 m -120.1 122.9 42.07 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.156 -1.383 . . . . 0.0 109.884 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.34 171.54 10.33 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.616 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 143.47 31.76 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.3 tt -99.61 133.47 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.584 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 p -44.38 148.41 0.46 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.734 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.15 59.44 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -60.87 -56.41 21.44 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.444 ' H ' ' HG2' ' A' ' 40' ' ' MET . 29.3 mmt -54.87 -31.24 59.46 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.011 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -71.94 -42.98 65.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -80.77 -6.34 58.38 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 5.0 m120 -114.13 -10.74 12.77 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.244 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 48.3 m-85 -159.55 140.98 12.91 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.164 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 46' ' ' ARG . 2.4 tt -51.65 174.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.046 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' N ' HG23 ' A' ' 45' ' ' ILE . 11.9 ttp180 -70.45 130.63 42.42 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.671 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.53 HG13 HD23 ' A' ' 48' ' ' LEU . 4.5 tt -82.86 147.35 5.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 48' ' ' LEU . 2.5 pt? -59.14 157.44 10.4 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.667 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -61.46 151.88 31.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.717 1.246 . . . . 0.0 112.264 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 79.78 79.59 0.84 Allowed Glycine 0 C--N 1.272 -3.028 0 CA-C-N 112.478 -2.146 . . . . 0.0 108.864 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 53' ' ' VAL . 46.0 m-20 -108.08 120.11 41.4 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 113.497 -1.351 . . . . 0.0 107.953 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -74.34 115.11 13.49 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 115.386 -2.525 . . . . 0.0 104.536 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG21 HG12 ' A' ' 67' ' ' ILE . 13.2 m -130.68 168.6 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -95.07 118.54 32.05 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -101.47 146.8 9.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.409 -0.917 . . . . 0.0 112.95 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 1.8 tp10 -126.02 129.58 49.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 7' ' ' PHE . 67.3 mt -93.12 130.08 38.87 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.704 -1.198 . . . . 0.0 111.136 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' ASP . 70.4 p -66.81 156.28 87.41 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -43.77 -26.27 1.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.165 1.243 . . . . 0.0 110.851 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -75.47 -34.31 60.89 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 58' ' ' THR . 5.2 t0 38.81 48.79 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.104 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -104.86 -67.29 0.92 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.491 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 t -138.7 9.71 2.64 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.683 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -129.04 148.33 50.98 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.478 1.132 . . . . 0.0 113.666 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.67 -173.86 25.68 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -137.59 160.0 40.4 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.31 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.745 HG12 HG21 ' A' ' 53' ' ' VAL . 7.9 mt -104.31 137.42 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.597 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -162.15 85.37 0.59 Allowed 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.415 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.54 ' CB ' ' O ' ' A' ' 68' ' ' THR . 74.4 t80 118.75 125.52 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 O-C-N 126.047 2.092 . . . . 0.0 109.186 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' HB3' HG12 ' A' ' 53' ' ' VAL . 13.2 ptt-85 -151.96 157.73 42.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.636 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.99 155.65 46.45 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 116.317 -1.802 . . . . 0.0 111.282 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mmm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 t -149.98 111.1 4.38 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -0.89 50.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.72 170.09 17.21 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.804 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 6' ' ' SER . 1.1 p30 -111.91 -115.75 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 63.3 p -58.37 -172.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.836 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -150.72 138.84 20.15 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.573 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -104.67 132.96 50.29 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.729 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -161.2 132.15 5.33 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.756 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' SD ' ' A' ' 9' ' ' MET . 8.9 mt-10 -79.33 145.67 33.33 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.643 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.09 -178.01 26.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.438 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -113.15 156.14 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.045 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLY . 38.3 t -106.35 108.89 26.19 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' CG2' ' C ' ' A' ' 13' ' ' VAL . 0.1 OUTLIER -153.56 83.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 C-N-CA 117.184 -1.806 . . . . 0.0 111.785 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.5 m-20 167.99 142.39 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 113.234 -1.803 . . . . 0.0 107.389 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.4 p -116.41 124.77 50.86 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 118.917 -1.113 . . . . 0.0 112.241 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 22' ' ' PHE . 1.7 mp -101.76 165.73 13.48 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.542 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 30.7 Cg_endo -97.82 162.04 0.86 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.698 0.932 . . . . 0.0 111.723 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.631 ' C ' ' SD ' ' A' ' 21' ' ' MET . 0.9 OUTLIER 79.1 19.72 0.76 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.312 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.557 ' C ' ' SD ' ' A' ' 21' ' ' MET . 3.2 m 81.53 64.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.631 ' SD ' ' C ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -153.92 160.98 42.33 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.975 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 17' ' ' LEU . 90.6 m-85 -136.25 159.2 42.47 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HE ' ' CB ' ' A' ' 15' ' ' ASP . 1.3 ttp-105 -111.71 144.67 40.61 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.411 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.89 149.58 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -114.12 110.96 20.83 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 122.35 1.071 . . . . 0.0 112.219 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' ASN . 38.3 mt -106.33 36.1 2.72 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 103.239 -2.875 . . . . 0.0 103.239 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.867 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.43 -6.61 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.821 -1.991 . . . . 0.0 112.583 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' LEU . 3.3 m-20 -70.88 25.43 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.867 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.79 -10.21 18.67 Favored Glycine 0 CA--C 1.558 2.748 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.84 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' O ' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -124.8 146.67 49.12 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.18 136.43 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -146.26 172.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.618 -1.633 . . . . 0.0 113.561 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.604 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.3 m -115.77 129.96 56.66 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.034 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.0 -179.87 6.63 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 118.691 -1.203 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.576 ' CD2' ' N ' ' A' ' 35' ' ' HIS . 1.6 m-70 -132.76 166.57 21.91 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.686 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.6 tt -98.27 118.64 45.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.712 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 m -67.59 -174.85 0.45 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.382 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.93 -9.47 59.74 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 10.2 mptt -45.82 -30.31 1.64 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.733 ' SD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -68.07 -49.32 62.06 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.761 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.733 ' N ' ' SD ' ' A' ' 40' ' ' MET . 9.3 mtp85 -47.98 -47.51 32.96 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.169 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.37 -40.86 95.86 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.288 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 10.3 m120 -93.65 23.41 4.71 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.596 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 72.5 117.61 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.523 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -43.17 116.9 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.153 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.622 ' C ' HD12 ' A' ' 47' ' ' ILE . 10.7 ptm180 -156.02 135.87 12.68 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.583 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.939 ' N ' HD12 ' A' ' 47' ' ' ILE . 2.3 mp -109.16 135.85 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.5 tm? -134.98 120.68 19.48 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.043 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.536 ' N ' HD22 ' A' ' 48' ' ' LEU . 53.9 m -71.52 118.02 13.81 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.527 1.156 . . . . 0.0 110.898 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.98 78.83 0.71 Allowed Glycine 0 C--N 1.264 -3.467 0 CA-C-N 112.714 -2.039 . . . . 0.0 109.433 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 4.4 t0 -108.59 128.07 54.51 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -74.33 114.76 13.07 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 115.216 -2.593 . . . . 0.0 105.414 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 67' ' ' ILE . 27.3 m -125.05 165.62 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 10' ' ' GLU . 39.6 ttm-85 -96.83 115.2 27.02 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.79 136.46 32.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -109.54 119.11 38.42 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.497 ' N ' ' OE1' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -94.51 146.39 24.13 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.2 p -104.01 144.54 28.89 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.106 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -22.97 75.11 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.546 1.497 . . . . 0.0 111.196 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.49 -21.96 59.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.48 85.62 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.502 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LYS . 3.0 mp -53.31 -29.81 35.65 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.606 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 t -56.49 -2.71 0.08 Allowed 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.139 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' LEU . 7.4 mtpm? -132.39 144.54 50.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.66 -172.03 30.64 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.69 162.55 32.43 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.158 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 53' ' ' VAL . 13.2 mt -103.59 136.01 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.921 -1.112 . . . . 0.0 111.533 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 67' ' ' ILE . 1.4 p -161.87 86.22 0.63 Allowed 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.431 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CB ' ' O ' ' A' ' 68' ' ' THR . 65.6 t80 123.27 137.48 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 O-C-N 126.073 2.108 . . . . 0.0 108.112 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -154.26 157.63 39.01 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 117.592 -1.643 . . . . 0.0 113.638 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.8 138.6 52.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.395 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 C--N 1.308 -1.204 0 CA-C-O 116.261 -1.828 . . . . 0.0 110.808 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.907 0.384 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -171.61 122.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -155.91 64.82 0.58 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.748 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 4' ' ' GLU . 22.5 mp0 -86.44 -95.21 0.08 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.491 -0.883 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 61' ' ' ASP . 8.1 t0 -156.14 -64.59 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.864 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -46.17 121.75 3.51 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.461 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 6' ' ' SER . 0.2 OUTLIER 172.25 -173.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.919 -1.112 . . . . 0.0 110.894 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -89.28 149.7 22.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.276 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -160.49 135.04 7.46 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.561 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -81.84 146.4 29.89 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.184 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.48 -177.04 34.22 Favored Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.927 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 24' ' ' VAL . 84.8 m -120.76 149.31 42.75 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.633 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' GLY . 47.5 t -105.65 108.32 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.723 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 49' ' ' THR . 0.1 OUTLIER -146.03 82.51 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.563 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.465 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER 170.73 143.24 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 112.977 -1.92 . . . . 0.0 108.641 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -117.14 137.23 52.45 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.448 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 17' ' ' LEU . 28.8 mt -123.42 170.36 8.53 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.805 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 19.8 Cg_endo -96.65 161.67 1.15 Allowed 'Trans proline' 0 C--O 1.212 -0.813 0 C-N-CA 120.484 0.789 . . . . 0.0 110.929 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' CG ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER 77.34 28.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.138 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m 67.46 62.74 0.44 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.722 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.432 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 9.0 mmt -143.05 162.69 34.84 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.992 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 21' ' ' MET . 9.4 m-85 -149.14 159.16 44.49 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.81 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . 27.5 ttp180 -110.4 135.23 51.43 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.51 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 12' ' ' THR . 11.3 p -113.32 133.75 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -92.98 125.12 37.42 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.878 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.712 ' C ' ' H ' ' A' ' 28' ' ' ASN . 63.7 mt -111.93 35.75 3.59 Favored 'General case' 0 C--N 1.267 -3.012 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.846 ' C ' ' H ' ' A' ' 29' ' ' GLY . 12.4 tp10 -37.01 -6.49 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.425 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.712 ' H ' ' C ' ' A' ' 26' ' ' LEU . 17.2 m-20 -70.64 25.91 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.846 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 116.37 -15.25 15.26 Favored Glycine 0 CA--C 1.56 2.899 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.33 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 26' ' ' LEU . 3.0 t60 -125.25 156.16 38.98 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' C ' ' CG2' ' A' ' 32' ' ' VAL . 2.2 p -131.55 138.34 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG12 ' H ' ' A' ' 33' ' ' THR . 2.3 t -149.71 170.93 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.363 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.68 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -116.82 141.79 47.76 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.762 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.44 173.48 14.5 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.465 -1.294 . . . . 0.0 111.265 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.448 ' CD2' ' N ' ' A' ' 36' ' ' ILE . 8.2 t-160 -122.83 137.18 55.0 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.13 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' N ' ' CD2' ' A' ' 35' ' ' HIS . 0.1 OUTLIER -82.32 137.49 21.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.62 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.9 m -69.9 138.97 52.89 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.918 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 42' ' ' LYS . . . -79.21 -29.28 50.92 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.465 -1.35 . . . . 0.0 110.384 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -58.98 -59.27 5.73 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.774 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.0 mmt -61.48 -31.41 71.39 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.672 HH21 ' NH2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -80.46 -22.17 41.34 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.652 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 38' ' ' GLY . 21.0 tptp -74.16 -28.17 61.18 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.652 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' O ' ' CG ' ' A' ' 44' ' ' TYR . 24.4 t-20 -83.34 -7.31 59.6 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.777 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m-85 -162.51 132.11 4.43 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.993 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 44' ' ' TYR . 20.8 mm -41.42 152.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.964 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -79.43 125.23 29.27 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.049 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.518 ' CD1' ' HE ' ' A' ' 70' ' ' ARG . 78.2 mt -69.33 148.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.666 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 48' ' ' LEU . 2.6 pp -57.21 177.21 0.09 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.067 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 14' ' ' VAL . 87.4 m -49.87 150.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.482 1.134 . . . . 0.0 112.726 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 76.53 78.36 0.72 Allowed Glycine 0 C--N 1.281 -2.526 0 CA-C-N 112.895 -1.957 . . . . 0.0 108.9 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -109.92 118.34 36.21 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.474 -1.363 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 8.5 mtpm? -76.04 113.6 13.74 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 115.43 -2.508 . . . . 0.0 104.573 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 70' ' ' ARG . 25.0 m -132.55 -178.2 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.731 ' CZ ' ' CD2' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.09 117.24 34.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.269 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.14 132.99 45.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.528 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -107.45 132.24 53.42 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.3 125.76 38.07 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.065 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 61' ' ' ASP . 68.2 p -66.04 158.12 77.61 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.702 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -42.27 -21.0 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 120.942 1.094 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 58' ' ' THR . 2.1 m-85 -88.54 -34.94 17.21 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 58' ' ' THR . 3.8 p30 38.39 32.5 0.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.484 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.01 -65.76 0.97 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.677 -1.609 . . . . 0.0 109.782 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.542 ' H ' HD12 ' A' ' 62' ' ' LEU . 14.9 m -137.4 0.47 2.3 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.787 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.97 148.74 41.91 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.454 1.121 . . . . 0.0 113.942 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.69 -173.12 29.96 Favored Glycine 0 C--O 1.199 -2.074 0 N-CA-C 107.386 -2.285 . . . . 0.0 107.386 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -138.07 153.71 49.31 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.995 -1.082 . . . . 0.0 109.657 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.567 HG23 ' HB ' ' A' ' 53' ' ' VAL . 51.4 mt -102.97 140.53 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.657 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' THR . 1.1 t -162.61 87.47 0.6 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 118.479 -1.289 . . . . 0.0 110.591 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.731 ' CD2' ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER 120.72 95.88 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 126.251 2.22 . . . . 0.0 109.878 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.742 ' HA ' HG12 ' A' ' 53' ' ' VAL . 19.8 ptt-85 -96.5 152.92 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.066 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.68 155.66 45.67 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.699 -0.801 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' CD ' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p 59.19 170.45 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 53.59 82.08 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 88.6 mt-10 -153.56 -40.52 0.1 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.821 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER 68.82 154.79 0.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.747 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 7' ' ' PHE . 4.9 t -64.57 174.47 1.74 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.617 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' N ' ' OG ' ' A' ' 6' ' ' SER . 6.6 t80 -145.38 -179.82 6.91 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' PHE . 72.5 mm-40 -132.57 135.53 45.98 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.7 tpt -160.59 134.47 7.03 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.142 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -74.0 147.33 43.06 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.95 156.46 27.21 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.193 -1.479 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.491 ' C ' HG23 ' A' ' 24' ' ' VAL . 6.1 m -96.52 149.37 21.82 Favored 'General case' 0 C--O 1.203 -1.385 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.117 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 50' ' ' GLY . 43.3 t -105.35 106.87 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG22 ' C ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -150.58 85.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.78 0 C-N-CA 117.806 -1.558 . . . . 0.0 110.575 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.78 141.99 0.03 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 112.779 -2.009 . . . . 0.0 107.52 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.1 p -108.8 146.47 33.56 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.539 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 17' ' ' LEU . 30.9 mt -129.58 169.87 12.23 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.878 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 24.9 Cg_endo -96.74 160.87 1.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 120.654 0.903 . . . . 0.0 110.753 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' PRO . 2.9 t30 76.66 31.04 0.58 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 m 63.45 64.63 0.8 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.407 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 34.7 mtt -140.33 168.44 19.8 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.76 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' CG ' ' C ' ' A' ' 21' ' ' MET . 4.0 m-85 -150.04 158.99 44.73 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HE ' ' HB2' ' A' ' 23' ' ' ARG . 3.9 ttm180 -114.23 146.82 39.9 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.546 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 12' ' ' THR . 4.7 p -124.34 136.85 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.068 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.71 126.02 38.65 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.644 1.211 . . . . 0.0 113.257 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.686 ' O ' ' N ' ' A' ' 28' ' ' ASN . 83.1 mt -112.72 35.34 3.91 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.825 ' C ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -36.94 -5.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 112.047 -2.342 . . . . 0.0 112.636 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 26' ' ' LEU . 11.6 m120 -70.82 25.32 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.825 ' H ' ' C ' ' A' ' 27' ' ' GLU . . . 115.72 -10.99 18.59 Favored Glycine 0 CA--C 1.56 2.864 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.886 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.453 ' O ' ' C ' ' A' ' 26' ' ' LEU . 4.0 m-70 -125.12 155.6 39.63 Favored 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -129.77 147.1 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.773 HG12 ' N ' ' A' ' 33' ' ' THR . 93.3 t -151.6 175.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 117.236 -1.786 . . . . 0.0 112.456 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.773 ' N ' HG12 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -122.85 134.27 54.4 Favored 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 113.413 -1.722 . . . . 0.0 107.363 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.74 176.62 8.54 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.788 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -137.55 146.93 44.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.743 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 tt -77.31 146.03 9.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.646 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -73.18 161.11 30.96 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.97 -45.34 9.13 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.134 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -48.21 -50.3 29.78 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.544 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 mtt -61.22 -35.85 78.33 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -56.89 -40.09 75.6 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.051 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' TYR . 70.3 mttt -71.62 -34.4 69.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.384 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.679 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 7.7 t30 -69.1 22.31 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.951 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.679 ' CD1' ' C ' ' A' ' 43' ' ' ASN . 17.4 p90 41.18 59.97 2.17 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.088 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 45' ' ' ILE . 18.4 mm -102.28 86.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.49 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -42.47 130.57 3.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.45 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 47' ' ' ILE . 2.1 pt -87.31 141.96 13.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.65 158.77 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.638 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.5 t -76.24 135.19 39.68 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.582 1.182 . . . . 0.0 111.592 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . . . 75.91 78.82 0.66 Allowed Glycine 0 C--N 1.272 -3.011 0 N-CA-C 107.657 -2.177 . . . . 0.0 107.657 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 13' ' ' VAL . 64.4 m-20 -107.44 118.38 36.57 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.514 -1.343 . . . . 0.0 107.924 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -75.46 112.04 11.38 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 115.269 -2.572 . . . . 0.0 104.091 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' HB ' HG23 ' A' ' 67' ' ' ILE . 33.9 m -135.15 -178.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.388 -1.325 . . . . 0.0 114.304 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 54' ' ' ARG . 8.8 ttm180 -102.6 117.44 34.68 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.073 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG21 HG11 ' A' ' 24' ' ' VAL . 2.1 t -101.92 127.51 55.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.318 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -103.64 131.37 50.86 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.23 129.19 39.36 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.729 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 61' ' ' ASP . 67.9 p -66.14 155.78 86.49 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.885 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -43.0 -24.99 0.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HB3' HD21 ' A' ' 62' ' ' LEU . 11.8 m-85 -75.7 -36.8 59.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.221 -0.991 . . . . 0.0 108.688 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 58' ' ' THR . 14.7 t70 45.48 35.31 1.92 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.995 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 63' ' ' SER . 0.0 OUTLIER -95.13 -65.51 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.858 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 62' ' ' LEU . 4.6 m -137.96 -13.42 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.444 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -106.13 150.71 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.14 -172.88 26.84 Favored Glycine 0 C--O 1.203 -1.81 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -141.95 156.73 45.47 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 53' ' ' VAL . 45.3 mt -103.92 139.79 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.784 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 67' ' ' ILE . 2.3 p -161.08 85.15 0.67 Allowed 'General case' 0 C--O 1.209 -1.031 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.279 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' THR . 72.6 t80 130.85 136.86 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.82 0 CA-C-N 112.376 -2.193 . . . . 0.0 107.826 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' N ' ' CD ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -138.47 150.17 46.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.612 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 52' ' ' LYS . . . -141.47 153.16 44.79 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.733 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 116.198 -1.858 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 stop_ save_